Home Blog Page 44

CMO toughens alcohol guidelines

Dame Sally DaviesMen should drink no more than 14 units of alcohol per week, according to strict new guidelines from the chief medical officer. The previous recommendation was 14 units for women and 21 for men.

The Department of Health (DH) says the revised guidelines are based on a ‘detailed review of the scientific evidence’ and supported by a new statement from the Committee on Carcinogenity (CoC) on the links between alcohol and cancer. ‘Drinking any level of alcohol increases the risk of a range of cancers,’ states DH.

The new guidelines also recommend that people do not ‘save up’ their units for one or two heavier drinking sessions, as well as urging people to drink more slowly, alternate alcoholic drinks with water and have ‘several alcohol-free days a week’. They also revise the existing guidance for pregnant women, stating that ‘no level of alcohol’ is safe, rather than the previously recommended one to two units.

The aim is to reduce the mortality risk from cancer and other diseases, says the government, as the ‘links between alcohol and cancer were not fully understood’ when the guidelines were first published in 1995.

‘Drinking any level of alcohol regularly carries a health risk for anyone, but if men and women limit their intake to no more than 14 units a week it keeps the risk of illnesses like cancer and liver disease low,’ said chief medical officer Dame Sally Davies. ‘What we are aiming to do with these guidelines is give the public the latest and most up to date scientific information so that they can make informed decisions about their own drinking and the level of risk they are prepared to take.’

The new guidelines were welcomed by Alcohol Concern as way of raising awareness of potential health harms. ‘Beyond liver disease, the public’s understanding of the health problems associated with alcohol is low,’ said chief executive Jackie Ballard. ‘The public have a right to know what they’re consuming and these recommendations are designed to allow people to make an informed choice about how much they drink.’

Industry body the British Beer & Pub Association (BBPA), however, warned that the male recommendations now put the UK ‘well out of line’ with comparable countries such as Spain (35 units), Italy (31.5) or the US (24.5). ‘In other countries, most guidelines recognise the difference in terms of physiology and metabolism between men and women,’ said chief executive Brigid Simmonds. Cutting the limit also meant classifying ‘a whole new group of males’ as at-risk drinkers, she said, with the ‘real danger’ that people would simply ignore the advice.

A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC) at www.gov.uk

February 2016

Drink and Drugs Nws
Drink and Drugs News February 2016

In this month’s issue of DDN…

New report – new action?

Over-50s are the focus of a new report on harmful drinking, with a new report from the Drink Wise, Age Well programme (see our latest issue). One of the main issues to be identified is the widespread confusion around units and guidelines, with three quarters of the 17,000 people surveyed unable to correctly identify recommended units. So will the government’s new alcohol guidelines (our lead news story) help?

      Send us your views!

      PDF / Virtual Magazine

 

From little acorns…

There’s still time to book… https://www.drinkanddrugsnews.com/conference

‘Don’t get mad, get organised’ said Si Parry from Morph at the first DDN national service user involvement conference in 2008, and it was a message that set the tone for this dynamic event, as delegates spoke out, question­ed, participated – and most of all claimed it as their conference, giving it a unique life of its own.Conference collage

While more than 500 people attended that first conference, most delegates were coming wearing the badge of their local drug and alcohol action team (DAAT), and while there were a few nascent service user groups attending they were clutching homemade leaflets and often completely reliant on their local service for survival.

Fast forward nine years, and how things have changed. Many of the groups that were just starting out back then – and some that weren’t even a twinkle in their founders’ eyes – have developed beyond all recognition. The 2015 conference saw a service user exhibition area filled with professional stands and high quality materials to rival the larger treatment providers.

Of course it’s not a story of untrammelled success, and sadly some groups have not survived round after round of budget cuts. It would also be naive to claim that starting and funding a group is easy, and most successful groups credit the support they received from a local commissioner or drug worker who believed in them and backed them from the early days. It’s a long hard slog making sure service users are represented meaningfully, and the purpose of the conference has never been clearer.

Many groups have managed to grow far beyond their original remit, and engage in a wide range of activities that would have been hard to imagine when they started up. Across the country we’ve been charting some highly motivated groups prepared to challenge stigma and support their members’ personal journeys. Peer-led groups now operate as equal partners supporting local treatment services, contributing widely to the community. Campaigning for national naloxone provision and other outreach initiatives has also seen groups break down the traditional barriers between harm reduction and recovery to share common ground.

Peter Yarwood from Red Rose Recovery was inspired to start a group after hearing speakers at a previous year’s DDN conference. ‘Our organisation is here for people who aren’t yet members – it’s for people that don’t know who we are yet,’ he said.

Hopefully this year’s event will once again be the empowering networking opportunity that will inspire service user groups and recovery groups to start up, grow and flourish all over the country.

See you in Birmingham!

Media savvy

media savvy paper

The news, and the skews, in the national media…

 

There is no perfect template for reform. Different countries have had vastly different experiences. Culture, fashion, demographics and economics all play a part – arguably a bigger part – than state enforcement. But the international trend is moving away from the crudest form of ban-and-punish regime. Most cannabis users do little harm to themselves or others, except by funding organised crime, a function of illegality. Many who might otherwise dabble unscathed end up harmed by the consequences of prohibition: street products of unpredictable strength; career-ending convictions for minor offences; retail contact with gangsters.

Guardian editorial, 8 March

Whether you support cannabis decriminalisation or not, it’s clear that the Lib Dems have limited ability to actually influence government policy. They have eight MPs now. Eight. Less than one seventh of the number they had in 2010… The Lib Dems had a chance to stand up for young people and they blew it. It’s insulting they think this ‘cool dad’ act might be enough to turn things around.

Abi Wilkinson, Guardian, 9 March

The Big Dope lobby and its many suckers and dupes constantly attack me for pointing out the dangers of the drug they want to legalise… When will the twin lies that there is a ‘war on drugs’ and that taking cannabis is a harmless, peaceable recreation, be exposed for the dangerous falsehoods they are?

Peter Hitchens, Mail on Sunday, 27 March

The attitude towards drinking in this country is getting increasingly bizarre. On the one hand you have that laugh-a-minute health chief who says she can’t even look at a glass of wine without ruminating on the increased risk of breast cancer, on the other you have our motley crew of lads and ladettes drinking themselves into oblivion in city centres… And then there are the rest of us, the vast majority who like a glass of wine or three but tend not to run amok or pick fights on aircraft and yet are still constantly berated for a nighttime snifter.

Virginia Blackburn, Express, 10 March

Governments worldwide need to learn one crucial lesson from the emergence of NPS. Their emergence is directly related to global prohibition and the war on drugs we have been fighting for over 100 years, a war that has had few successes.

Karenza Moore, Independent, 4 March

 

 

Reach out

Chris RintoulChris Rintoul reports positive results from a Northern Ireland naloxone programme

The Scottish Drugs Forum (SDF) watered the seeds of take-home naloxone and it allowed us to kick-start the programme in Northern Ireland. Before that we had no naloxone, and no sight of it.

People are dying – especially poor groups, people in poverty, and drug-related deaths are concentrated in these groups. People who need naloxone are likely to be people who are most disaffected. They’re not hard to reach – more easy to ignore for far too long.

Some of the action involved aggressive campaigning. I was a social worker – and that involved activism. I got active and aggressive. Service user activists and social workers pushed for us to be able to give out naloxone.

The Council for the Homeless in Northern Ireland is moving towards training for the trainers in naloxone. We developed a lot of partnerships with all stakeholders, including the Housing Executive, voluntary sector agencies, the ambulance service, and the police, and looked at the viability, efficacy, and effectiveness of naloxone. We sometimes arrive late on substitute prescribing etc – but we’ve done well on this.

People are now offered naloxone at a very early part of their treatment. We have posters and leaflets that reinforce the messages and push further for it. Take-home naloxone programmes need courageous people with credibility; people who are experts in their area.

There are opportunities now – the law change has let us expand. Outreach services and hostels can now give it out, as can pharmacies, alongside needle and syringe distribution.

Overdoses are down – we had seen them rise and rise over the decade, so to see a significant drop last year was a great thing. I can’t say that it was specifically naloxone – only time will tell. The Public Health Agency for Northern Ireland is going to devolve funding to local trusts. But because it’s in their contracts, it will be difficult for them to step away from naloxone.

Buff [Iain Cameron] and I decided we wanted to support take-home naloxone, so we developed an app and funding followed. We want to do an update, if we find the funding.

You have loads of credible and courageous people in this country – get them involved.

Chris Rintoul is lead trainer for Street Rx in Northern Ireland. He spoke at the HIT Hot Topics conference in Liverpool

 

Words for the wise

Harry ShapiroHarry Shapiro has launched a new drug information service with his former DrugScope colleague, Jackie Buckle. He tells us more

I am very pleased to announce the launch of DrugWise, a new online drug information service carrying on the drug information tradition of DrugScope and – for those of you with long memories – its predecessor, the Institute for the Study of Drug Dependence.

As you can imagine, 2015 was a ‘bit of a year’, but with the generous assistance of the field, my colleague Jackie Buckle and I were able to continue with the seamless delivery of DS Daily directly to subscribers, five days a week. We also set up a legacy website so that people would have access to all the reports and information sources of DrugScope. But this did set me wondering.Jackie Buckle

DrugScope had two main functions; one was to be the advocacy agency for drug and alcohol treatment and focus on the attendant policy issues affecting drug users, such as welfare reform and mental health. The other half of our work focused around general drug information in all its various manifestations, for anybody who needed it – information that was up to date, evidence-based and non-judgmental.

With the demise of DrugScope, the advocacy work was taken up by Collective Voice while Making Every Adult Matter (MEAM) carried on with the related policy issues. But there remained an information vacuum and I was still being contacted by journalists for comment and background on the usual wide range of issues. And so Jackie and I came to the decision to set up DrugWise and with the very welcome assistance of the Brit Trust, the site is now up and running.

DrugWise will perform a number of functions. For a UK audience, we will update and develop drug information from DrugScope, write new thematic reports on topical issues and provide an archive not only of DrugScope reports, but hopefully in time, a complete and searchable archive of Druglink magazine articles back to 1986. The site will also be a platform for the public affairs work I am currently involved in around the issue of prescribed and over-the-counter drug dependency through the All Party Parliamentary Group on Prescribed Drug Dependence and the Opiate Painkiller Dependency Alliance. I will also be continuing the media, lecturing and public speaking work under the DrugWise umbrella.

But the ambition is for DrugWise to be more international and to broaden the focus beyond drugs to alcohol and tobacco. From a health and wellbeing perspective, it has never made much sense to separate out these substances when there are so many synergies in terms of harm reduction, treatment and recovery and education and prevention – and not least because most of those with serious drug problems are also often smoking and drinking.

Certainly across the spectrum of global drug policy, there is a growing demand that policy should be evidence rather than morally-based – and since the advent of e-cigarettes, a public health hearts and minds battle has broken out between experts with all the rancour normally associated with the drugs war. So it seems that now more than ever, it is important for policy-makers and practitioners to have access to the best evidence available across substances and interventions.

One problem though is that the material is often spread across national and international agencies and so what the DrugWise I-Know international knowledge hub aims to do is to try and bring together the most robust and reliable documentation in one place. However, every country has its own health, prevention and criminal justice systems and cultures and so there is no attempt to analyse the material – simply bring it to the attention of professionals across the disciplines.

These are the basic building blocks of DrugWise and despite the solid foundations on which it is built, it is nevertheless early days. But we are very keen to get your ideas and feedback about the service and how you think it might develop – and we will be very keen also to engage in partnerships where drug information and communications input is required.

There is every indication that the treatment sector will be coming under increasing financial pressure, so here’s hoping you all can navigate safe passage through the choppy waters of the coming months.

Contact Harry Shapiro or Jackie Buckle at www.drugwise.org.uk.

Learning for life

Richard JohnsonEducation and training are often discarded when substance use takes over. Richard Johnson describes how ANA’s new programme is helping clients to reconnect

ANA was founded in 1998 for people who have become reliant on drugs and/or alcohol and provides residential treatment centres in Hampshire. As part of our philosophy of abstinence, we have developed a toolkit to strengthen resilience and recovery capital among our diverse client group.

We developed an approach to education with a local further education provider, Highbury College in Portsmouth – a partnership that was recognised as good practice by the NTA in 2010 – and have been building on it since.

Over the last two years we have been working closely with the college to have our second stage treatment programme, called our Road to Recovery course (R2R), accredited as a qualification in its own right. It combines therapeutic inputs with a life skills programme, delivered through a series of seminars and workshops.

As part of the course, clients are expected to complete workbooks and, although we make provision for those who cannot or prefer not to use the written word to express themselves, most do choose to use them. We had all of our workbooks retyped and printed and our lecture notes and presentational aids revamped, including power points, lesson plans and hand-outs, and put everything in individual folders for each client to be given upon admission.

The workbooks are added to other materials to compile an individual portfolio for each client. In building these portfolios, we realised just how many educational skills our clients acquire throughout the process; it soon became clear that many of our clients had become more self-aware and had developed better interpersonal, problem solving and practical skills since going through treatment.

We tentatively showed the client portfolio to the Community Education Department at Highbury College and they enthusiastically confirmed that the portfolio had significant educational value, resulting in their accreditation. The college has been enormously supportive, visiting ANA to train the R2R staff and counsellors. Clients are also invited on a tour of the college, in preparation for further education after our second stage.

So far, 12 clients have successfully completed the R2R course and received an accreditation, through their own recovery, from the college – an enormous achievement for each of them. The course is accredited at level one, which means that many clients will not have to undertake an access course when starting college, giving them back a year of their lives in study time.

The course is helping to break down barriers to education for clients and equip them with additional skills for life. Access to education was one of the key priorities in the government’s 2010 drug strategy, and is likely to continue to be so. The qualification makes recovery tangible; it demonstrates what clients have to do, what they have achieved and what they are capable of doing in the future. It also supports the concept of ‘better than well’ and has a very great impact on client recovery capital and self-esteem.

Rosanna O’Connor, director of alcohol, drugs and tobacco at Public Health England commented: ‘There is a very significant need for better education, training and employment support for people in drug and alcohol treatment, whether in the community or in residential rehab.

‘This project, being developed by ANA, is an excellent example of how some treatment providers are taking the initiative, providing people with tailored educational support, leading to qualifications, skills and the essential confidence needed to access employment.’

The next stage is to seek national accreditation and invite other treatment providers to have their programmes accredited. We feel that the initiative facilitates very positive community reintegration through study and education, and helps people take confident strides towards the job market.

Richard Johnson is CEO of ANA Treatment Centres and ANA Works, www.anatreatmentcentres.com

Tough measures

Kit CalessKit Caless examines some of the issues behind the rush to outlaw new psycho­active substances (NPS)

The third reading of the Psychoactive Substances Bill took place in Parliament on 20 January, and is due to be become an act on 6 April 2016. The bill has been subject to some controversy over definitions, not least the chance that poppers (alkyl nitrites) could be outlawed – which led to MP Crispin Blunt ‘outing’ himself as a popper user during the debate in Parliament. The accuracy of reports on harm, efficacy of a blanket ban, and accusations of rushed legislation have been consistently raised. One of the major issues with NPS has been a sharp rise of misuse in UK prisons.

In December 2015 HM chief inspector of prisons, Nick Hardwick, released a hard-hitting, upfront report on the misuse of substances in prisons. In the report he stated that NPS have created ‘significant additional harm’ and ‘are now the most serious threat to the safety and security of the prison system that our inspections identify.’ At the time the report was being made, ‘there was an acceleration in the use and availability of NPS’. Synthetic cannabinoids like Spice and Black Mamba were used by 10 per cent of those surveyed. This is much higher than in the community, where only 6 per cent of those surveyed said they had used synthetic cannabinoids in the two months before going into custody.

Right now, NPS are banned in prisons, but their legal status and wide accessibility outside the prison gates makes them an attractive proposition for smuggling into prisoners. As Hardwick’s report states, ‘despite the high mark-up, they [NPS] are still relatively cheap in prisons.’ On top of this, current testing methods cannot detect synthetic cannabinoids, and new testing regimes can struggle to keep up with ever changing composition. It takes time to develop new drug tests, change legislation and develop new resources. When you’re testing for such a variety of chemical compositions, the NPS market likely always remains one step ahead.

Media reports have tended to focus on novel smuggling techniques, including drugs in tennis balls catapulted over prison walls, or even flown in using drones. Category C training prisons, which have large perimeters and relatively free prisoner movement as they go to and from work, are most susceptible to drugs coming over the wall. Of course, usual routes are also taken, through social visits and internal corruption. Hardwick controversially states that, ‘it has sometimes been difficult to make best use of the information available from individual establishments and other sources to identify changing needs and modify the strategy accordingly. In part, this reflects a too-willing acceptance in some establishments that drug misuse is an inevitable part of prison life and cannot be reduced.’

The danger of NPS use in prisons is highlighted in the report through anecdotal and quantitative evidence. Nineteen deaths in prison occurred between April 2012 and September 2014, where the prisoner ‘was known, or strongly suspected, to have been using NPS-type drugs before their deaths.’ The report surveyed more than 10,000 prisoners and found that, ‘debt associated with synthetic cannabis use sometimes leads to violence and prisoners seeking refuge in the segregation unit or refusing to leave their cells. Debts are sometimes enforced on prisoners’ friends or cell-mates in prison, or their friends and families outside.’

Not every prison has the same issues and it is not just the supply of NPS that is the problem in the UK prison network. Why have NPS become so attractive to prisoners? What can be done to tackle these problems? Should the focus, as some argue, be on the reasons why drugs are used in prison (boredom, demotivation, corruption), or on testing and punishment for usage? Hardwick says that any new strategy ‘needs to go beyond specific drug services to reducing demands for drugs by offering attractive purposeful alternatives, reducing prison violence and creating positive staff prisoner relationships.’

Kit Caless is Addaction’s communications officer for London and the south

There are no quick and easy answers to any of the questions posed by the prevalence of NPS in Britain and its prisons. But the debate is still in full swing.

You can join in by attending ‘New psychoactive substances: no longer a novelty – the expert view’,

15 March in London.

Details at http://bit.ly/1nl0Kzr

 


 

‘It’s unworkable’

Harry Sumnall

The psychoactive substances bill is an Niamh Eastwood unnecessary and unworkable law, Niamh Eastwood, Release’s executive director, told the HIT Hot Topics conference, as the ‘unstoppable’ bill was rushed through parliament.

‘It’s opened a Pandora’s Box,’ she said. Media reports of our streets being ‘awash with these drugs’ meant that ‘we have to respond, regardless of harm or prevalence… but it’s a tiny number compared to the treatment system not being responsive to the needs of people accessing it.’

The Centre for Social Justice had used its Broken Britain report to justify the progress of the bill through the House, said Eastwood, quoting Vice, that ‘the death stats that government’s using to ban legal highs are total bullshit’.

Last year’s Global Drug Survey (GDS) had highlighted the extent of alcohol and tobacco use. But prohibition was not about the drugs, said Eastwood, it was about ‘social control’ and ‘the othering of certain groups’, including young people in deprived areas and people in prison.

The bill had not only created ‘a number of strange possession offences’, but penalties showed ‘no proportionality’. Furthermore the ban on exportation and importation of psychoactive substances for personal use meant head shops would close and people would buy ‘dodgy stuff’ online.

Quoting ACMD advice to the Home Office that ‘the psychoactivity of a substance cannot be unequivocally proven’, Eastwood said it was an example of needing to speak out when things were wrong. Proving psychoactivity was difficult, making the legislation unenforceable.

‘Get out there and tell people that this is one of the worst pieces of legislation ever drafted,’ she said. ‘It’s an affront to our brains.’

Professor Harry Sumnall, of the Centre for Public Health at Liverpool John Moores University, said that from looking at treatment data, NPS didn’t seem to be an issue for treatment services – a long way from Neil McKeganey’s picture of ‘a scourge that could grow to eclipse heroin’, reported by the Scottish Daily Mail.

We were becoming prone to ‘risk illiteracy, where we don’t have a good handle on risk,’ he said. This could make us powerless to act or react.

The key message to emerge was, ‘don’t panic, we already know what to do’, said Sumnall. Existing approaches were ‘entirely suitable’, with classic harm reduction components ‘absolutely vital’, including messages around not sharing syringes.

‘It’s not about new drugs,’ he said. ‘We’re not seeing new and novel harms… It’s about understanding cultural practices.’

Burden of grief

Esther Harries

Helping families through the guilt and anger of losing a loved one can be gruelling for practitioners. Esther Harries looks at how to be prepared

The Bereaved Through Substance Use Guidelines were launched in June 2015 and represented the culmination of joint research between the Universities of Bath and Stirling on the experiences of families bereaved through substance use.

In the introduction, the guidelines invite practitioners to seek effective clinical supervision while working with family members following bereavement.

Although the focus is on practitioners who come into contact with substance-related deaths, the research could be equally valid for family support practitioners – particularly if they are working with the family and the client in treatment, where family meetings are integrated into the care plan.

McAuley & Forsyth (2011) conclude that ‘when someone dies of a DRD it is not only the needs of friends, family, or witnesses that need to be taken into account. The presence of grief-related reactions in almost 90 per cent of this sample suggests that staff who were involved in the care and treatment of the deceased also need to be considered when dealing in the aftermath of the event.’

Their study of the impact of a drug-related death on those who have experienced it as part of their caseload found that 65 participants were identified as having experienced at least one drug-related death on their caseload and 88 per cent identified at least one reaction: ‘The most common feelings identified were sadness (83 per cent); guilt (40 per cent) and anger (37 per cent): 26 per cent reported feeling helpless; 21.5 per cent had cried and 18.5 per cent had difficulty in concentrating.’

Burden of griefAs a counsellor and clinical supervisor, I have witnessed the following thoughts and feelings from both family members and practitioners:

Guilt – ’I should have…’

Grief

Disbelief: ’They were doing so well…’

Anger – Perhaps directed towards the treatment system for its perceived failures.

Sad reflection: ‘What if..?’

Practitioners can also be supporting families with a loved one’s addiction as they experience a series of losses, ‘a living bereavement’, that includes the fear that their loved one may die. The intensity of this work can, without proper support, have considerable impact on the psychological well-being of the practitioner, particularly if they are involved in a serious case review and/or an appearance at the coroner’s court.

The trauma therapist Michael Gavin (www.embodiedtherapy.net) acknowledged in 2015 how challenging working with trauma can be: ‘People tell you stories of unbearable experience, and you have to listen’.

He states that the aim of supervision is to make therapy as safe and effective as it can be for both practitioner and clients or patients. For example, practitioners might be helped to improve their skills in specific ways (see box).

McAuley and Forsyth (Journal of Substance Use, February 2011) add that ‘providing a debriefing session and one-to-one support, like that proposed by Redinbaugh et al (2003), on both the events leading up to death, and staff feelings and emotions in its aftermath, should be available to those who need it and, therefore, should be considered for future policy and practice. It can also deter any notion of a ‘blame culture’ being developed and promote a working environment where each death can be used as an opportunity to reflect and learn lessons for the benefit of future practice’.

Practitioners might be helped to:

Master the skills of self-awareness, mindfulness, and of managing both their own arousal, and that of clients.

Find and cultivate their own reliable sources of safety and resilience, both internal and external.

Build a capacity for a calm yet assertive personal presence.

Foster their individual talents, style and insights as a basis for a sense of personal authority.

Find a way back to common sense (not so common!) and a sense of humour in the face of the unbearable and ‘unspeak-about-able’.

Esther Harris is an independent practitioner in counselling and clinical supervision

Hit Hot Topics

Stigma, misunder­standing and a lack of communication cloud our policy and practice on drugs, said speakers at HIT Hot Topics. DDN reports on their ideas for a fresh approach. Photos by Nigel Brunsdon

‘As long as drug users are marginalised and stigmatised there are going to be harms,’ said Pat O’Hare, opening HIT’s annual Hot Topics conference. The question was, how could we tackle this against a backdrop of disinvestment, where harm reduction was being ‘dismantled bit by bit’?

Alex StevensAlex Stevens, professor at the University of Kent, used statistics to show how drug deaths were misused, ‘to scare and to support ineffective policies’. The attention on new psychoactive substances (NPS) had brought ‘the most radical departure in drug policy’ – but meanwhile heroin deaths had increased by 64 per cent.

‘So why aren’t we focusing on heroin? Because of who these people are,’ he said.

Death rates were particularly linked to deprived areas in the north of England, and specifically to men who had lost industrial jobs in the 1980s and ’90s and turned to heroin use as ‘it was all there was’. This group was now middle aged and becoming very vulnerable.

Looking at how deaths were reported in the national papers gave a snapshot of how different drug users were perceived. Following deaths from NPS, descriptions typically included the words ‘brilliant, student, gifted’. Heroin or methadone deaths were more likely to contain language related to ‘junkie’.

This discrimination was used to support ineffective policies, the psychoactive substances bill, prohibition in general, cuts and churn in services, and recommissioning, he said. Not only were people were being written off as ‘not useful’, but ‘the shortage of public funds is being used as an excuse for lack of action,’ he said.

So how could we try to change public perception – and therefore change policy?

Carl HartUS professor and research scientist, Carl Hart, threw a challenge to the audience to embrace ‘the three Cs’ – their convictions, capability and courage. Commenting that ‘you British are very controlled’, he said ‘I’m going to ask that you get a little more angry.’

‘Drugs are used as scapegoats,’ he said, quoting examples such as a newspaper headline from the 1930s: ‘Negro cocaine fiends are a new southern menace’…‘I hope this gives you conviction to change our narrative,’ he said. Using capability and courage involved critical thinking and calling on the facts to challenge exaggerated science.

‘One of the facts that people ignore is that 80-90 per cent of drug users do not have a problem,’ he said. ‘You have to have courage to tell people we have exaggerated the harmful effects of drugs. You have to have courage to challenge scientists in a public space.’

It was not a formula for popularity, he acknowledged. ‘Be prepared to lose funding, friends, professional achievements and respect… but history will judge you favourably because you are right.’

‘Hold them accountable with the facts,’ he added. ‘You have to publicly embarrass people. If you don’t, our people quietly suffer.’

Bengt Kayser, teacher and researcher at the University of Lausanne, Switzerland, explored the topic of doping to demonstrate a culture of exaggerated responses and moral panic. ‘Myths get a ring of truth because they are published in a scientific journal,’ he said. ‘Debunking this type of myth is important.’ Responses could become exaggerated and moral panic could too easily turn into a moral crusade.

‘Sebastian Coe is dangerous for harm reduction in England because he pushes zero tolerance,’ he said. There were risks, he acknowledged, but it was important to keep them in proportion, ‘or people will run away from us.’ Harm reduction was the answer, coupled with evidence-based policy-making. To have any hope of changing the narrative, we needed to spread clear and effective messages, according to Jamie Bridge and Nigel Brunsdon, who gave insight into using photo-based campaigns. ‘Back in the old days, campaigning was left to the TV,’ said Brunsdon, showing images of some of the most effective public health campaigns, such as ‘Charlie says’ (child safety), ‘Don’t die of ignorance’ (Aids) and ‘Coughs and sneezes spread diseases’. Back then there was no immediacy, with months of lead-up time for publishing in magazines. Modern devices, however, brought the opportunity of hashtags and hundreds of immediate hits.

Recalling the ‘Support. Don’t punish’ Facebook page, he said: ‘I can join in an international campaign just like that. All the barriers are taken away from me.’ The #SupportDon’tPunish campaign had borrowed from successful campaigns such as #NoH8 (against anti-gay marriage legislation), #NotinMyName (young Muslims showing solidarity against terror attacks) and the #BeTheGeneration Global Fund campaign, to create a global day of action around the world, added Bridge.

‘We constantly struggle with the stigma of our cause,’ he said. But if you had a sellable idea you could keep finding reasons to bring it back into public consciousness. ‘Keep pushing,’ he urged, ‘you need to bring it to people.’ Brunsdon gave tips and tricks to help change the narrative through viral campaigns. ‘You can’t force a campaign to go viral, but you can nudge it along,’ he said. ‘Give people the tools and tell them what you want them to write. The more barriers you remove to action, the more likely it is to happen… Have simple messages, be original, have goals and targets. Have good simple hashtags.’

Brunsdon illustrated this with a preview of his new website, harmreductionisbeautiful, due to go live in a few weeks. The site aimed to overturn the way drug use and harm reduction were perceived.  ‘It’s about changing the narrative – it’s always depressing images of injecting in alleyways, and never celebratory. The idea is simple – you put up messages and have a selfie with it. Any of you can contribute to this and can download any of the images to use.’

Ethan NadelmannEthan Nadelmann of the Drug Policy Alliance brought a perspective from the US that zoomed in on Liverpool, the conference venue, as ‘the birthplace of harm reduction’.

‘Americans have no interest in what’s happening outside our country,’ he said. ‘We continue to fall tragically short in areas where you have led the way… areas like physician independence in prescribing.’ But, he continued, ‘when I hear how bad it is here right now, with the decimation of resources, the demonisation of people who use drugs, the sense of fear of people trying to do the right thing, the indifference to human life that this government is demonstrating, I know that place very well.’ We needed to keep pushing forward while playing good defence as well, he said, and this involved ‘addressing the fears of those who oppose us.’

The US was still involved in ‘the horrific drug war’ of the late 1990s, which had perpetuated incarceration. We had to think ‘how do we shift public views?,’ he explained. Nadelmann used the example of cannabis – medical marijuana – to show how the nature of debate could be shifted, and how ‘we could play ball in the big league of US politics’.

‘We changed the image of a marijuana user, from a kid to an older woman recovering from breast cancer, or someone recovering from Aids,’ he said. ‘When the pictures were shown, they touched the hearts of the hardest Republican. We focused on what we had in common.’

Equally important was finding ‘what drives our opposition’ – ‘Fear is the driving element of the war on drugs, fear of not knowing how to deal with diversity,’ he said. This involved using their language (‘pivotally important’) and exploring common ground: ‘We’re doing recovery and it works. “Grant us the serenity…” That is the prayer of the drug policy movement as well.’ It was about taking ‘unlikely voices and allies’ and embracing common values, Nadelmann told the audience.

‘Being as open and responsive as possible will lead you out of this dark period and restore you as the leader of the world in dealing with drugs.’

Concluding a thought-provoking day enhanced by plenty of audience interaction, Pat O’Hare concluded: ‘Drug policy reform is the best harm reduction. Keep the faith, keep the passion.’

News in brief

Bill blasted

An early day motion on the Psychoactive Substances Bill has been tabled by Paul Flynn MP. ‘This House regrets the depth of scientific illiteracy’ in the bill, it states, adding that the document is ‘evidence-free and prejudice-rich’. A proposed amendment to exempt alkyl nitrites, or ‘poppers’, from the legislation was defeated last month, and both houses have now agreed on the text of the bill, which is waiting for the final stage of Royal Assent before becoming an Act of Parliament.

Crack on

The number of people estimated to have started using opiates and/or crack in 2013 was between 5,000 and 8,000, according to Home Office statistics. The figures represent a fall of around a fifth compared to 2005 and are down ‘hugely’ since the 1980s and ‘90s, says New opiate and crack-cocaine users: characteristics and trends. The downward trend has ‘flattened since about 2011, but available data do not suggest that this is the precursor to a new increase’, the report states. ‘If anything, the downward trend may resume in 2014, though the situation requires further monitoring.’ Report at www.gov.uk

Ketamin call

Ketamine should not be placed under international control, the World Health Organization (WHO) has ruled. The substance ‘does not pose a global public health threat’ and controlling it could limit access to anaesthesia and pain relief in many parts of the developing world, it warns. The drug’s medical benefits ‘far outweighed’ the potential harm from recrea­tion­al use, said WHO’s Marie-Paule Kieny, adding that an international ban could ‘limit access to essential and emergency surgery, which would constitute a public health crisis in countries where no affordable alternatives exist.’

Synthetic threat

New psychoactive substances – particularly synthetic cannabinoids – are now the ‘most serious’ threat to safety and security in British jails, according a report from HM Inspectorate of Prisons. Changing patterns of substance misuse in adult prisons and service responses studies the evidence from more than 60 inspections and 10,000 survey responses from individual prisoners, and calls for the establishment of a national committee, chaired by the prisons minister, to bring together ‘cross-government and cross-sector expertise’.

Report at www.justiceinspectorates.gov.uk;

Emergency measures

A&E attendance rates for alcohol poisoning doubled from 72 to 148 per 100,000 population between 2008-09 and 2013-14, according to a report from the Nuffield Trust. Rates were highest among ‘older, poorer men’, says Alcohol-specific activity in hospitals in England. ‘At a time when unprecedented efficiencies need to be made by the NHS and local authorities, preventative action must be taken seriously,’ says the trust.

Document at www.nuffieldtrust.org.uk

A dog’s life

The Dogs Trust is looking at ways to help homeless hostels become dog friendly, as less than 10 per cent currently accept dogs. ‘We know from our own experience of working with dog owners that most would rather remain on the streets than be forced to give up their four-legged friend,’ says Homeless Link.

Hostel staff can fill in a survey at www.surveymonkey.co.uk/r/welcomingdogs

Priced outShona Robison

The final decision on minimum unit pricing in Scotland will be taken by domestic courts, the Scottish Government has stated, following a ruling by the EU Court of Justice that the proposals could breach European law by ‘significantly’ restricting the market. ‘The Scottish Government remains certain that minimum unit pricing is the right measure for Scotland,’ said health secretary Shona Robison, despite the EU court recommending the use of tax measures – which would still allow competition between retailers – instead.

Ketamin call

Ketamine should not be placed under international control, the World Health Organization (WHO) has ruled. The substance ‘does not pose a global public health threat’ and controlling it could limit access to anaesthesia and pain relief in many parts of the developing world, it warns. The drug’s medical benefits ‘far outweighed’ the potential harm from recreational use, said WHO’s Marie-Paule Kieny, adding that an international ban could ‘limit access to essential and emergency surgery, which would constitute a public health crisis in countries where no affordable alternatives exist.’

Keep it breif

A review of the effectiveness of brief interventions in emergency department settings has been published by EMCDDA. These can provide a ‘unique window of opportunity’ for engaging with otherwise hard-to-access people, says Emergency department-based brief interventions for individuals with substance- related problems: a review of effectiveness. Available at www.emcdda.europa.eu

Smokeless funds

Around 40 per cent of UK local authorities are cutting their budgets for smoking cessation services, according to a report from Cancer Research UK and ASH, which also reveals high levels of recommissioning and reconfiguration. ‘Most local councils take their responsibility to reduce smoking very seriously, but they are facing enormous funding pressures,’ said ASH policy director, Hazel Cheeseman. Reading between the lines: results of a survey of tobacco control leads in local authorities in England at www.cancerresearchuk.org

Naloxone notes

A new Europe-wide review of the case for distributing naloxone has been published by EMCDDA. Preventing opioid overdose deaths with take-home naloxone includes good practice and training examples, and also looks at the legal barriers to distribution. ‘Each of the lives lost every day in Europe to opioid overdose is worth all our efforts to improve prevention and responses’, said EMCDDA director Alexis Goosdeel. Available at www.emcdda.europa.eu

Gang guidance

The government has promised more action to address the exploitation of vulnerable people in the drug trade, as part of new measures to tackle gang violence. Nine areas across the UK will receive targeted support from experts to help address local challenges, it said.

Social space

Many LGBT people begin drinking heavily when they first encounter the commercial gay scene, with an ‘expectation that they continue to do so’, according to a new report from Glasgow Caledonian University and Scottish Health Action on Alcohol Problems (SHAAP). Many also feel that alcohol services and peer support would not provide a ‘safe or welcoming space’, says The social context of LGBT people’s drinking in Scotland. Report at www.gcu.ac.uk

Peer pressure

Expanding peer support could be one way of lessening the impact of the government’s cut to the public health grant, according to a new RSA report. PHE should drive the development of a ‘creative commissioning for recovery’ approach to improve local outcomes, says Whole community recovery: the value of person, place and community. ‘Services are being asked to do more for less, so there needs to be a focus on doing things differently, harnessing the capacity within the system,’ said Susie Pascoe, the RSA’s whole person recovery programme lead. Report at www.thersa.org

Painkiller practicalities 

A new web-based resource to support the ‘safe and rational’ use of opioid medicines, Opioids Aware, has been launched by the Royal College of Anaesthetists’ faculty of pain medicine and PHE, aimed at prescribers, patients and carers. Nearly 23m prescriptions for opioid painkillers were written for UK patients in 2014 alone, the resource highlights.

All change

A new project to support the families and carers of change-resistant drinkers has been launched by Adfam and Alcohol Concern as a follow-up to last year’s successful ‘Blue Light’ project. The organisations are looking to roll out the initiative as widely as possible, so any local areas interested in getting involved should contact Mward@alcoholconcern.org.uk.

Generation drink

Julie BreslinA major new report sheds light on the alcohol habits of the over-50s. Are they risking drinking themselves into an early grave?

Last month the government revised its sensible drinking guidelines for the first time in 20 years, bringing the recommended weekly levels for men down to match those for women – at 14 units (see news story, page 4). One reason for the revised limits, says the government, is that the links between alcohol and cancer were ‘not fully understood’ when they were first issued in 1995.

Now a new report from the Drink Wise, Age Well programme, whose partners include the International Longevity Centre (ILC-UK) and treatment charity Addaction, highlights the fact that it may well be the over-50s who are most risking their health through their drinking habits. Drink wise, age well: alcohol use and the over 50s in the UK is the largest ever study of its kind, surveying nearly 17,000 people from across the country. It found a population whose problem drinking may well be ‘hidden in plain sight’.

Not only were age-related issues such as bereavement, retirement, loneliness, money worries and loss of a sense of purpose leading people to drink more in many cases, those people were also far less likely to seek help. Nearly 80 per cent of those identified as higher-risk drinkers drank ‘to take their mind of their problems’, says the report, with ‘not coping with stress’ the strongest predictor for being a higher-risk drinker.

A quarter of respondents had no idea where to look for support – and said they wouldn’t ask for help even if they did know – while more than 80 per cent of those identified as being at increased risk from their drinking had never been asked about it by a professional. More than half of over-65s also thought people ‘had themselves to blame’ for any alcohol problems.

Although most survey respondents were found to be lower risk drinkers, a ‘significant minority’ were not, says the document, and it’s a problem that’s likely to get worse. More than a third of the UK population is over 50, and by 2040 nearly one in four will be 65 or above, shoring up major problems if the ‘drinking patterns of older adults do not change’. Between 1991 and 2010, alcohol-related deaths among the 55-74 age group in England increased by 87 per cent for men and 53 per cent for women, meaning there is a ‘pressing need’ for action to reduce alcohol-related harm.

As the report points out, the image that harmful alcohol use tends to conjure up is one of young people binge drinking. Is the issue of older drinkers still largely a hidden one? ‘Very much so,’ head of the Drink Wise, Age Well programme, Julie Breslin, tells DDN. ‘Quite often drinking in later life takes place behind closed doors, and therefore is not as visible as young people’s drinking in a town or city centre of a Saturday night. Also our report shows a high level of stigma for older drinkers, so it’s quite possible that if there is an issue they won’t tell anyone.’

The report highlights the lack of a coherent plan to address alcohol-related harm in older drinkers, so what could be done at government level – should there be a national strategy? ‘From a starting point we’d like to see more consistent UK-wide collection of data on alcohol use and older adults,’ she says. ‘For example, PHE have only recently started collecting alcohol statistics on adults aged 75 and over, and in order to compare and assess the scale of the problem we’d like to see some consistency in the information gathered across the four nations. Secondly, we’d like to see alcohol and ageing on the agenda across a number of cross-care areas, such as dementia, retirement, social isolation. Alcohol use doesn’t happen in a vacuum.’

The programme is also advocating for the needs of older people to be specifically highlighted in existing government strategies, in order to raise the issue in professional and commissioning circles. ‘Up until now only the Wales and Northern Ireland alcohol strategies particularly reference the needs of older adults,’ says Breslin.

One of the major issues identified by the report is a widespread confusion and lack of awareness around units and guidelines. Will the recent revisions go some way to rectifying that or is there still a lot more to be done to get a clearer message across? ‘In our report nearly three quarters of respondents were unable to correctly identify recommended units,’ she says. ‘Hopefully the new guidelines are a good starting point and easier to digest. However for many people even the concept of “units” is difficult to grasp and we may need to work together to find better ways to communicate the message. It would be helpful to provide resources that allow people to self-measure and start to understand their own consumption better.’ The drinks industry also needs to share a responsibility in getting the message across, she stresses – they may have put unit information on labels but it ‘could be a lot bigger’.

As older people have been drinking for longer, the harm becomes accumulative, she points out, although the fact that over-50s are far from a homogenous group is itself a challenge. ‘You could have an extremely fit and healthy 73-year-old, versus a 52-year-old with multiple health issues. We think more discussion and exploration is required in relation to the guidelines and how we provide nuanced age-specific advice.’

There’s always been a strong Alcohol units graphanti-‘nanny state’ feeling in the UK, however, and many are likely to say, ‘If they haven’t got much else in their lives let them enjoy a drink – why take that away?’

‘The “nanny state” backlash is certainly something we’re prepared for and we saw this very much in the recent revision of the alcohol guidelines,’ she says. ‘However we believe that older people in particular do play an active role in their own health and wellbeing, and given the right information make healthier choices. How alcohol affects us, particularly as we age, is something most people would want to know about in order to make this choice, in the same way they would take care of other health areas.’

Assuming that older people don’t want to make healthy choices or live active and healthy lives is an ageist approach, she argues, adding that when they do access alcohol treatment they tend to have better outcomes – the problem is that they’re less likely to engage with treatment in the first place. ‘Assumptions that people are too old to change are unhelpful and actually quite discriminatory,’ she states.

If the aim is to help people experience a better quality of life in their later years, a key starting point is ‘clear and credible information’, she stresses. ‘Many people identified positive reasons for alcohol use such as socialising and relaxation, and these are important factors for people as they age. We’re not telling people not to drink – we’re highlighting what the particular risks are for older people and proving advice and information.’

People have to be motivated to improve their health, however. If someone is lonely, perhaps bereaved, and feel they have little to live for they may well know they’re doing themselves harm but think, ‘So what?’ What, realistically, can be done to counter that?

‘Of course major life transitions such as bereavement and retirement can be a trigger for increased alcohol use, and people may feel that there’s little in their life to change for. In our direct engagement and support service, where we work with people over 50 who are already drinking problematically, our philosophy is that it’s our job to help people find the motivation that will help them make that change. Very often the first stage of engagement is about relationship building and dealing with practical issues.’

The problem, she points out, is that it’s resource- and time-intensive. ‘We are very lucky to be funded so we can work in this way,’ she says. ‘What can happen with busy generic addiction and social work services is resources may be stretched, and if an older person – on the face of it – is not showing motivation to change, resources may be allocated elsewhere. We know that it takes time, repeated home visits, and lots of patience for someone to start to find their own drive for making a change, and this is the model we adopt.’

Equipping people with social supports and coping strategies – ‘resilience interventions’ – is also vital, she says, so that when they do experience difficult life changes they are better able to cope without turning to alcohol.

The report says that what’s needed is an ‘age-nuanced’ approach – what would some of the elements of that look like? ‘At a wider level there needs to be a multi-agency approach to ensure older adults don’t fall through the net,’ she says. ‘Frontline staff and practitioners should receive training that specifically challenges stigma and attitudes, whilst equipping people to better recognise and respond to older people who may be drinking.’

Among the best-placed people to step in are health professionals, particularly GPs, as they’ll usually be the ones older people have the most regular dealings with. What can be done to raise awareness among them, and help them spot any warning signs? ‘Health professionals have more and more demands on their time, but better alcohol screening of patients is a good starting point and in some areas this is already offered. If older patients are re-presenting with issues such as low mood, sleep disorders, stomach problems, then alcohol use may be a contributing factor.

‘It also may be the case that whilst people are not drinking at particularly high risk levels, they are experiencing some health implications due to age-related changes,’ she continues. ‘It’s important for community agencies to work closely together so that GPs have an easy and accessible referral route when they do identify someone.’

www.drinkwiseagewell.org.uk

Ireland considers consumption rooms and decriminalisation for personal use

Aodhán Ó Ríordáin

The Government of Ireland is considering the introduction of drug consumption rooms, as well as decriminalising small amounts of drugs for personal use.

The announcement was made as part of a speech by new communities, culture and equality minister Aodhán Ó Ríordáin, who has responsibility for the country’s national drugs strategy, to the London School of Economics IDEAS Forum.

Consumption rooms had proven effective in engaging hard-to-reach populations, said Ó Ríordáin, and he had asked officials to examine ‘proposals for the provision of medically supervised injection facilities’ in line with European and Australian models. This was partly to address problems with street injecting in Dublin and elsewhere, as well as a recent spike in blood-borne viruses, he said, telling the Irish Times newspaper that the facilities would ‘happen next year’. The country’s health minister Leo Varadkar, however, has stressed that while he supported the proposal it would require a change in the law and would not be ‘a simple matter’.

A drugs policy review has also been launched to consider whether a decriminalisation approach to the possession of ‘small quantities’ of drugs – such as currently operates in Portugal – should be considered in Ireland, although there was ‘certainly no desire for a permissive approach to drugs’, Ó Ríordáin emphasised.

While the country’s drug strategy was one that was ‘firmly focused on recovery’, a changing drugs landscape required renewed focus and innovation, he stated. ‘I am in favour of a decriminalisation model, but it must be one that suits the Irish context and be evidence based. I believe that this kind of approach will only work if it is accompanied by timely treatment and harm reduction services, backed up by wrap-around supports which foster recovery – such as housing, health and social care. Above all, the model must be person-centred and involve an integrated approach to treatment and rehabilitation based on a continuum of care with clearly defined referral pathways.’

 

Full speech at www.merrionstreet.ie

Media savvy

Media savvy december

Drug abuse and HIV continue to present profound challenges to the health of gay people, but a climate of moral panic and blaming the gay scene is counterproductive… We need a more sophisticated analysis of the reasons driving high-risk behaviour among some gay men. Without this under­standing, any future NHS responses to chemsex are destined to fail.
Marco Scalvini, Guardian, 10 November

A major reason for the media coverage of chemsex as destructive is that most of the first-hand accounts of the experience come from people who present it as a problem at sexual health clinics. The media then select the most horrifying of these…. As for the connection between chemsex and HIV transmission, there is little academic consensus on this.
Jamie Hakim, Independent, 25 November

Addressing chemsex-related morbidities should be a public health priority. However, in England funding for specialist sexual health and drugs services is waning and commissioning for these services is complex. English sexual health services tend to be open access, with costs charged back to local authorities. Drug services tend to be authority specific with users having to attend a service within their borough of residence. Despite the different funding streams, creating centres of excellence for sexual health and drug services could be a cost effective solution to diminished resources in both sectors.
BMJ editorial, 3 November

Around the world, about 25 countries including Australia, the Czech Republic, Portugal and Switzerland have initiated reform. Even Iran’s theocracy brought in progressive harm-reduction measures and has influential voices calling for cannabis and opium legal­isation. Slowly but surely we are seeing the end of stupid policies to prohibit drug use that are not only stunningly illiberal but damage users, families, communities and entire countries.
Ian Birrell, Independent, 9 November

If governments really want to limit the harm from drugs – saving addicts’ lives, crushing dealers’ profits and slashing the number of people who take them in the first place – then they must seize control of the market themselves.
Economist editorial, 7 November

If people are going to use narcotics, it is best they do so safely. Relaxing the legislation on drug use, coupled with access to injection rooms, really is our only way forward.
Lorraine Courtney, Irish Independent, 6 November

What do modern terrorists have in common? Yes, they are fanatical, and usually (but not always) from ethnic minorities. But there’s something else very interesting. They are invariably on mind-altering drugs, usually cannabis.
Peter Hitchens, Mail on Sunday, 22 November

Local news from the substance misuse field

Jason Flemyng‘LOCK, STOCK’ STAR GIVES BOOST TO RAPT DAY PROGRAMMES

Jason Flemyng, star of Lock, Stock and Two Smoking Barrels, lent his support to Alcohol Awareness Week (16-22 November) with a visit to two of RAPt’s London community pro­gra­mm­es – the Tower Hamlets Community Alcohol Team (THCAT) and the Island Day Programme.

He was among those at the event to speak about the effects of addiction, having seen his father struggle with alcohol.

‘I am only too aware of the stigma around it,’ he said. ‘These projects are brilliant – not only because of the incredible transformation it can help bring for those struggling with drink or drugs, but because of the support and understanding there is for families too.’

 

 DRINKAWARE PILOT KEEPS CLUBBERS STREETWISE

Young clubbers in the south west will be targeted through the Drinkaware Club, a six-month pilot by the alcohol education charity.

Joining forces with local police, community partnerships and police and crime com­miss­ioners (PCCs), Drinkaware has trained staff in bars and clubs to increase safety by reducing drunken anti-social behaviour. Working in pairs, club hosts will begin by talking to customers as the queue is forming and ensure they leave safely as the venue closes. ‘I am delighted at the level of engagement and support we have had from local partners,’ said PCC for Devon and Cornwall, Tony Hogg. ‘We have been working closely with local authorities, street pastors and the venues to put this pilot together.’

 

AWARDS RECOGNISE STERLING EFFORT IN TACKLING STIGMA

The first Marsh Recovery Awards have been presented at Addaction’s recovery con­ference in Manchester – a result of the charity’s partnership with the Marsh Christian Trust.

Chosen for their outstanding contributions to raising awareness and reducing stigma in the field of recovery, the winners were: Kerrie Hudson for ‘exceptional individual’; Club Soda for ‘exceptional activity’; peer supporters at RISE in Devon for ‘exceptional group’; Max Daly, author of the Narcomania column in Vice and Sarah Hepola, author of Blackout: Remember­ing the things I drank to forget, for ‘exceptional media’.

 

TREAT YOURSELF AT ONLINE AUCTION

Broadway Lodge has launched an online auction to raise funds for treatment. To be in with a chance of winning two full-hospitality tickets for a day at the races, framed shirts from football stars, Sunday lunch at the Doubletree Hilton, a laptop and many more prizes, visit www.broadwaylodge.org.uk.

 

DYFRIG HOUSE OPENS NEW DOORS TO HELP CARDIFF’S HOMELESS

dyfrig house 1A specialist accommodation and support centre has been set up at Dyfrig House in Cardiff to help homeless people with alcohol or substance misuse problems.

The 21 self-contained bedrooms with private ensuite toilet and shower facilities, will support residents towards independent living and have been described as ‘not a hostel [but] therapy’ by one resident.

Since opening in 1967, Dyfrig House has provided one of the few ‘dry’ homeless services in the city. The completely refurbished service – result of a partnership between Solas (which provides accommodation for homeless people)dyfrig house 2, Cardiff City Council and the Welsh Government – offers an individually tailored therapeutic support model.

Lee Sutcliffe, who feels he owes his life to Dyfrig House, said: ‘I was made to feel safe straightaway, which I hadn’t felt in a very long time… it’s a very, very special place indeed.’

 

WELCOME EVENTS PROVE POPULAR AT FORWARD LEEDS

A series of open mornings across the city have proved a successful venture for alcohol and drug charity Forward Leeds.

Lisa ParkerThe Wednesday morning events have introduced service users, local residents and businesses the facilities and given them the chance to meet staff, ask questions and learn about what goes on at the charity, including the needle exchange and other harm reduction activities.

The service’s executive director, Lisa Parker, said they were extremely pleased at the turnout at the events and added, ‘The events have also been an opportunity for us to recognise the hard work our staff do… we made sure each staff member got a Forward Leeds purple and pink cupcake.’

Dark days review of the year 2015

There wasn’t very much to celebrate in 2015, a year that saw both England and Scotland record their highest ever number of drug-related fatalities, while a surprise outright Conservative election win heralded yet more belt-tightening and austerity…

JANUARY

Among ever-increasing fears about the impact of new psychoactive substances, the Ministry of JusticeDDN cover feb announces a raft of punitive measures for anyone found using or supplying them in prisons. ‘If prisoners think they can get away with using these substances they need to think again,’ warns justice secretary Chris Grayling.

FEBRUARY

DDN’s eighth national service user conference, The Challenge, proves to be the liveliest yet, with a day of powerful presentations against a background of increasing anxiety in the field. DrugScope’s State of the sector report indicates that the fears may be well founded, with more than half of survey respondents reporting a reduction in frontline staff alongside widespread concerns about job insecurity and rapid commissioning cycles. The highly controversial notion of linking treatment to benefit entitlement hits the headlines again as the prime minister commissions Prof Dame Carol Black to conduct a review into sickness benefits, while Alcohol Concern chief executive Jackie Ballard backs the call for health warnings on alcohol labels. ‘Every other bottle of poison in the supermarket has a warning label on it,’ she tells DDN.

MARCHddn march 

The government announces that it is developing plans for a general ban on the supply of all emerging drugs – the first stirrings of what is to become the controversial Psychoactive Substances Bill – and DrugScope goes into liquidation, blaming its worsening financial situation. ‘It is with a heavy heart that the board has taken this extremely difficult decision’, says chair Edwin Richards.

APRIL

Five more NPS become subject to temporary banning orders, and Alcohol Concern accuses the drinks imay dnnndustry of using responsible drinking messages as just another way to promote its brands. Meanwhile, Dr Joss Bray writes in DDN that it’s time to put com­passion back into service provision.

MAY

There’s widespread surprise – not least within the party itself – when the Conservatives win a majority in the general election. The new government loses no time in announcing its ‘landmark’ blanket ban on all NPS, described by Release as ‘full blown regression’.

ddn juneJUNE

New substances are now being identified at a rate of two a week, the latest EMCDDA European drug report warns, although demand for heroin appears to be ‘stagnating’ across the continent. Delegates at the RCGP’s national drug and alcohol conference argue that GPs need to stay central to substance treatment, while the ‘Support. Don’t Punish’ campaign holds its third global day of action. Naloxone campaigner Philippe Bonnet, meanwhile, urges DDN readers to identify local champions, create networks and raise awareness of how cost-effective the intervention can be.

 

ddn july augustJULY/AUGUST

Bleak news as Scotland records its highest ever number of drug-related deaths, 16 per cent up on the previous year. The country still faces a ‘huge challenge in tackling the damaging effects of long-term drug use among an aging cohort’, says community safety minister Paul Wheelhouse. Prof Dame Carol black launches her review into ‘supporting benefit claimants with addictions and potentially treatable conditions back into work’ and ASH tells DDN that the Welsh government’s plans to ban the use of e-cigarettes in public places amounts to a misguided attack on an effective harm reduction tool, although the claim in a PHE report that the devices are 95 per cent less harmful than smoking tobacco proves divisive.

SEPTEMBER

More grim news as England follows Scotland to announce its highest drug death toll – although fatalities in Wales are down – prompting Addaction chief Simon Antrobus to call on the government to re-think proposed cuts to local authority health spending. ‘The stakes are simply too high to do otherwise’, he states. The European Court of Justice deals a blow to Scotland’s minimum pricing plans by stating that they could breach EU trade laws, while Portuguese health minister Fernando Leal Da Costa tells the pan-European Lisbon addictions conference that Portugal’s decriminalisation approach is a ‘sensible and rational’ one that other countries could follow. Recovery month sees a vibrant range of activities across the UK, and Dave Marteau’s DDN piece on the risks of diverted methadone ruffles some feathers.

ODDN octoberCTOBER

Another month, another stark report – this time from the ACMD, whose second publication on opioid replacement therapy for the Inter-Ministerial Group on Drugs warns that heroin treatment is being threatened by diminishing resources and constant rounds of ‘disruptive re-procurement’. Another group of MPs, the Home Affairs Committee, concludes that the government is rushing, and weakening, its psychoactive substances legislation, while Phoenix Futures cautions that people’s recovery is under threat from a ‘perfect storm’ of conditions in the UK’s over-heated rental market.

NOVEMBER

Chemsex hits the national headlines when a BMJ editorial calls it a ‘public health priority’ and a scathing report from the Institute of Alcohol Studies says the government’s ‘laughable’ public health responsibility deal for alcohol may be ‘worsening’ the health of the nation. Stirling University’s Rowdy Yates tells DDN that it’s time to get over the ‘residential bad, community good’ attitude, while Ian Sherwood writes that the sector needs to be braver in calling for drug law reform. The government’s spending review makes more cuts to cash-strapped local authorities, sending further shivers through a drug treatment sector expecting the worst and increasing demand for a meaningful drug strategy in the new year.

DECEMBER

Plans are already well under way for the ninth national service user involvement conference, Get the picture. See you there!

Festive Cheer

Bubic Christmas 1 This Christmas day will see the fifth Bubic Christmas dinner for our service users. Previous years’ events have been a huge success and provided a welcome and warm environment with a great community atmosphere.

Bubic (Bringing Unity Back Into the Community) is an award winning community-based organisation that provides support for drug users, ex-drug users, their families and friends. Our strength lies in our approach. We work in and around communities encouraging peer mentors to give those who are using drugs practical advice and emotional support to help change their lifestyle and learn life skills.

The Christmas Day event for our service users and volunteers is to help support them through an emotionally difficult time of year, with a full Christmas dinner served to 50 or more individuals. ‘It’s a worthwhile, charitable and peaceful event says Derwyn, a Bubic volunteer mentor and ex-service-user. ‘I enjoyed being a part of last year’s festivities and am eagerly anticipating this year’s event.’

In true Bubic style, the event is a community initiative and is only possible through the donation of people’s time and effort. A big thank you to organisations from within the community, including local Sainsbury’s stores in Tottenham, who support Bubic through providing donations. Haringey Mencap not only donate the use of their beautiful Grade II listed building but also assist, alongside Bubic’s staff and volunteers, in setting up for the event on Christmas Eve and provide transportation for our service users on Christmas Day.

John, a Haringey Recovery Service user, volunteered on Christmas Day last year. ‘I was struck by the diversity of the group, from single men like me to single women and couples, from the elderly to families, people with young children and babies, to people whom society has chosen to forget,’ he told The Worm magazine (featured in DDN, November, page 10).

BBubic Christmas 2ubic prides itself on providing a platform from which members of our community can raise themselves up and aspire to greater things. Those who have previously encountered negative responses due to past behaviour and criminal records are given opportunity, and through proving their skills and abilities with Bubic, move onwards and upwards. Mark Nash, now a successful programme manager both in prison and the community, says, ‘Coming through Bubic gave me a platform. If there was no Bubic there would be no-one to assist those coming out of prison.’

 

With Bubic gaining centre recognition from Gateway Qualifications, followed by direct claims status in 2015, we are now able to further build on this platform by providing relevant, recognised, bite-size qualifications that are achievable within a matter of weeks. These qualifications centre on increasing your confidence and self-awareness, learning new skills and enhancing existing knowledge with the goal of helping others within your community. They embody what Bubic is about and provide a recognised next step in the recovery process for our service users, as well as an opportunity for others to educate themselves and give back to their community.

We’re also planning to further expand our outreach programme, which is essential to our organisation as it enables us to connect with the hard-to-reach clients; we bring the service to them. Our client Dodger recalls, ‘Bubic have engaged me in the snow, when it was cold. They’ve come into crack houses and given me food and supported me in the early hours of the morning.’

We go where others fear to tread!

Contact Bubic at www.bubic.org.uk or 020 8808 6550 for further details about services – or if you are a service user in Haringey and would like to join them for Christmas dinner

Obituary – Judy Bury

Judy BuryChris Ford says goodbye to a passionate and inspirational colleague

It’s with great sadness that we announce the death of Judy Bury, who died peacefully on 13 October 2015 in Edinburgh. Judy was one of the most inspirational, passionate and intelligent women I have ever known.

Judy started her career in sexual health services and always campaigned for the underdog. She was a proactive founder member of Doctors for a Woman’s Choice on Abortion (DWCA) – always defending women’s right to choice.

Later she became a hardworking GP in Craigmillar, a socially deprived area of Edinburgh, where she was a tireless and popular doctor. When the epidemic of HIV spread amongst Edinburgh’s people who used drugs and gay men, Judy quickly became involved and before long was appointed GP facilitator to one of the first HIV facilitation teams, with the remit of educating GPs to cope with this new disease and manage people who use drugs in their practices. She was a brilliant teacher, and communicated effectively with fellow GPs, the community drug problem service and HIV agencies.

Before long, the Scottish Office asked her to help in the production of national guidelines for the management of drug users in general practice which, when published, were timely and well received.

Close to our SMMGP hearts, Judy was there at the beginning, helping to arrange both the first conference (now in its 20th year) and the newsletter. I remember her speaking at that first conference and saying we (general practitioners) needed to care for people and never judge them until they wanted to change.

Some of you ‘young uns’ might not remember her as she retired, because of ill health, about 11 years ago. But true to form even when unwell she fought tirelessly for the ‘Yes’ campaign in Scotland and gathered together a group of doctors to form Doctors for Assisted Suicide (DAS).

Judy always gave such a lot to people and causes she believed in. Many of us loved her, and after a difficult last illness she is at peace now.

Dr Chris Ford

‘Laughable’ alcohol responsibility deal has worsened nation’s health, says charity

Katherine BrownThe government’s controversial public health responsibility deal for alcohol has pursued initiatives ‘known to have limited efficacy’ while obstructing more meaningful action, according to a damning report from the Institute of Alcohol Studies (IAS). If the industry has used the deal to resist more effective measures, the deal may even have ‘worsened the health of the nation’.

The deal – a partnership between the government, drinks industry and voluntary sector – was first announced five years ago as part of the public health white paper (DDN, 6 December 2010, page 4). It was subsequently dismissed by Alcohol Concern as ‘the worst possible deal for everyone who wants to see alcohol harm reduced’ (DDN, April 2011, page 4), with the charity one of a number of bodies – including the Royal College of Physicians and British Medical Association – that refused to sign up.

The boycott meant that the deal was never a ‘genuine partnership’, says the document, with many of the organisations’ objections ‘vindicated in the four years since’. Implementation of the deal’s non-binding pledges – a new set of which were announced last summer (DDN, August 2014, page 4) – has frequently ‘failed to live up to the letter and/or spirit’, says the report, with ‘ambiguous’ goals and poor reporting practices also rendering any evidence on the deal’s effectiveness ‘limited and unreliable’.

The document also casts doubt on the deal’s future, as the government has not explicitly committed to its renewal since the election, and the partnership’s ‘alcohol network’ has not met in more than a year. IAS is calling for the deal to be abandoned and for the government to instead re-visit some of the ‘real evidence-based policies’ – including minimum unit pricing – promised in the 2012 alcohol strategy (DDN, April 2012, page 4).

‘This report reveals the full extent of the failures of the responsibility deal to address alcohol harm,’ said IAS director Katherine Brown. ‘Perhaps more worryingly, it indicates the deal may have delayed evidence-based actions that would save lives and cut crime, such as minimum pricing. To call this a “public health responsibility deal” for alcohol is laughable, as almost every independent public health body has boycotted it.

‘With no support from the health community, and no evidence of effectiveness, it would be absurd for this government to continue with such a farcical initiative,’ she continued. ‘With alcohol costing our society £21bn each year, we can’t afford to keep prioritising the needs of big business over public health.’

Dead on arrival? Evaluating the public health responsibility deal for alcohol at www.ias.org.uk

Zero tolerance, zero cure

Chris FordMikhail Golichenko

Russian drug policies are fuelling the escalating HIV epidemic, says Chris Ford with input from Mikhail Golichenko

Last week I asked Viktor how he was, as his health seemed to be deteriorating. He relapsed again despite a desperate attempt to undergo drug treatment at Russia’s most renowned drug treatment clinic, the National Research Center for Drug Dependence. He had started using ‘khanka’, which contains opium, aged 16 years, and then tried a number of other drugs but he always went back to injecting opioids. For the next few years he was in and out of prison, and then in about 2004 he found out that he was HIV and HCV positive. Prison was followed by several attempts at detoxification, as this was the only drug treatment available, but each time he relapsed.

Last October the Russian government’s health committee held a meeting to discuss the rapidly growing HIV epidemic. The minister of health said that, at the current pace, the epidemic would grow 250 per cent by 2020 and any control would be lost completely – and suggested that HIV treatment coverage should be significantly expanded to include more people from vulnerable populations, including people who use drugs.

Authorities in Russia are aware that sharing contaminated injecting equipment by people who inject drugs remains the main driver of the epidemic (more than 57 per cent of new cases in 2014). Despite this, Russian officials continue with their dogmatic approach to harm reduction and in particular OST. Ignoring the overwhelming scientific evidence, the UN recommendations, and numerous examples of countries which successfully use OST for HIV prevention and drug treatment, Russia maintains a criminal ban on OST.

In 2010-2013 three Russian people (applicants) who use drugs went to the European Court of Human Rights (ECHR) challenging the criminal ban. All applicants are people who inject drugs with very similar stories of many years of opioid use and all its consequences, including HIV, hepatitis C, TB, prosecution by police, and incarceration. In the ECHR the applicants claimed that by denying them access to OST the Russian authorities had violated their right to be free from inhuman or degrading treatment, the right to private life, and the right to be free from discrimination.

Arguing against the applicants in the ECHR, the Russian case was based on a number of myths and misinterpreted facts, such as methadone once being called Adolphine after Adolf Hitler, or that OST medications lead to mental dementia, liver failure, or increased risk of overdose in comparison to heroin use. Authorities also try to mobilise drug treatment doctors, patients and their parents against OST. In October 2015 the ECHR received a 4,000 page submission from the Russian Government with signatures of several thousand people against OST, including doctors, patients, and their parents.

In addition each applicant suffered different persecutions: one applicant was arrested and interrogated about her OST application, another applicant suffered harassment by the authorities against a civil society organisation which provided support for him, and yet another applicant was fired from a government oriented drug treatment organisation for his position in favour of OST.

The legal battle in the ECHR is an example of how poor understanding of human rights by law enforcement and health authorities prevent science-based and cost-effective HIV prevention. The Russian Government argues that the legal ban on OST is to promote the right to health; the legal ban is mandatory for all, so there is no discrimination of any kind. The arguments that the Russian Government present to the European Court of Human Rights (ECHR) are based on the notion that the low level of retention in abstinence-based treatment, which is the only method of treatment available in Russia, has nothing to do with low effectiveness of this method of treatment. The Russian Government insists that the main reason why people who use drugs return to drug use after drug treatment is their low motivation to stay abstinent.

According to the government, the introduction of OST will further demotivate people who use drugs from abstinence. Taking this one step further, the authorities insist that the awful health and legal risks people who use drugs face should scare and ‘motivate’ them into abstinence – this in spite of there being no scientific evidence to support such an argument. Further, from a human rights perspective, such logic is discriminatory as the authorities ignore the vulnerability of people who use drugs to the adverse health consequences of illicit drugs and its associated life style, or in some cases use this vulnerability as part of the official policy of zero tolerance to drug use.

Also argued is that OST medications could be diverted to the illicit market and that OST medications can be misused and can cause death from overdose. This ignores evidence that inexpensive safety measures as well as health workers’ training can effectively minimise such risks, making the legal ban on OST completely disproportionate and unnecessary.

The ECHR hearings will take place sometime in 2016. Meanwhile, due to the government’s stubborn resistance to OST, thousands of people who inject drugs contract HIV every year. The current denial of access to OST in Russia is not unlike the denial of access to ARVT in South Africa at one time where myths and the ignoring of clear evidence led to millions of unnecessary deaths.

Mikhail Golichenko is at the Canadian HIV/AIDS Legal Network; Chris Ford is at International Doctors for Healthier Drug Policies (IDHDP)

 

Leaner and keener

Paul HayesIn a climate of austerity the new drug strategy must grow from our successes, says Paul Hayes on behalf of Collective Voice

Next month the government will begin its formal consultation to inform the drug strategy due in March. So how far has the 2010 strategy delivered its aspirations, and what insights have the last five years given us to help shape drug recovery for the rest of this parliament?

In the 2010 strategy the home secretary set out an ambition to ‘reduce demand, restrict supply, and support and achieve recovery’. The prime minister’s view at the end of 2012 was that this had been achieved: ‘We have a policy which actually is working in Britain,’ he said. ‘Drug use is coming down, the emphasis on treatment is absolutely right and we need to continue with this to make sure we can really make a difference.’

Despite the day-to-day challenges of delivery and the uncertainty of future funding following the spending review, we should not lose sight of the big picture – what the PM said was right in 2012, and remains right now. The policy is broadly achieving its aims and has been built on three pillars: a powerful positive narrative, endorse­ment of the clinical evidence, and a commitment to continue to invest.

The strategy successfully reframed the treatment system around recovery as an organising principle. The balance between ambition and evidence established a new consensus about best practice, steering clinicians to use opiate substitution therapy (OST) to provide a gateway to recovery for everyone who could take advantage of this opportunity. It also gave a secure place to build motivation and capacity to change for those not yet able to take the next step. This enabled the treatment system to promote recovery at the same time as continuing to deliver crime reduction and public health benefits – the bedrock of the success described by David Cameron, which it would be extremely unwise to unpick.

Crucially the government also backed the strategy with cash. Despite the extreme pressure on the public sector, funding committed to delivering the drug strategy was protected as part of NHS expenditure.

The 2010 strategy got the big calls right. It shaped a new ambition for the sector focused on the individual drug user, reached consensus on how to best achieve this together with wider societal benefits, and gave the resources to enable it to happen. However it also called for supporting action on jobs, houses, mental health, and a range of other crucial interventions which have not been delivered. The task for the 2016 version is to continue to deliver evidence-based, recovery-focused interventions, but to also overcome the strategy’s failures in the following areas (see opposite for details):

  • Drug-related deaths
  • Jobs and houses
  • Integrating prison and community
  • Mental health
  • ‘Locally led, locally owned’

Knitting all of this together would be health and wellbeing boards, which would integrate the local authority’s concerns with the Clinical Commissioning Groups’ (CCGs) continuing responsibility for drug users’ physical and mental health, and police and crime commissioners’ interest in the crime reduction yield from treatment. With some notable local exceptions, very few people would argue that the system is working on a national level. Health and wellbeing boards are understandably focused on social care as their overriding priority. Drug users are not a priority for either LAs or CCGs, and the decline in acquisitive crime which access to drug treatment has helped bring about has eroded the police’s role as local champions of treatment.

Commitment to drug treatment varies among directors of public health who lead on this for local authorities. Public Health England (PHE) has disinvested from its local presence, limiting not only its ability to promote and share best practice, but also the local intelligence it previously provided which enabled Home Office and Department of Health to understand what was really happening on the ground.

From 2018, local control of public health will be further strengthened as the public health grant is replaced by direct local authority responsibility for funding from business rates receipts. Unlike in 2010, drug and alcohol treatment is no longer part of the protected NHS spend but will have to compete for resources in the much harsher local government environment.

Continuing to deliver what has worked and overcoming the deficits will become increasingly challenging over the next four years, as the cumulative 20 per cent real terms reduction in the public health grant, announced in the spending review, removes the stability of investment that underpinned the 2010 strategy. Investment in drug treatment increased threefold between 2001 and 2008, since when it has been broadly flat with a slight decline since 2010, and a significant shift of existing resources from drugs towards alcohol since 2013.

There will always be scope for more efficient use of resources, and the best commissioners are working with providers to use innovation and integration to sustain or even improve outcomes. However too often the response is mechanistic recommissioning resulting in wasteful churn, or to demand reductions in contract price only deliverable through reductions in the quality of delivery. The sector needs to collectively and realistically assess what can be delivered, and the new drug strategy provides a timely opportunity to match ambition with resource.

The ideal 2016 strategy would look very like its predecessor – the key difference being to identify how to deliver the joined-up services everyone has known we need for at least 30 years. Key to this will be how best to champion an agenda that is not a natural priority for most of the individuals and institutions responsible for its funding and delivery. Collective Voice will work closely with government to identify workable solutions to this long-standing problem on behalf of all providers and in the interests of service users, their families and their communities.

Paul Hayes leads the Collective Voice project, a group of third sector treatment providers including Addaction, Blenheim, Cranstoun, CRI, Lifeline Project, Phoenix Futures, Swanswell and Turning Point

Tread softly

Public Health Nurses

How can we tackle child safeguarding without risking disengagement? DDN hears a cautionary perspective from public health nurses.

This focus on child protection is a good thing – but there are real consequences of focusing on it too much,’ said Karen Hammond of the Centre for Alcohol and Drug Studies, speaking at the recent HIT Hot Topics conference in Liverpool.

Hammond gave insight into the changing role of public health nurses in relation to mothers who used drugs – and described a very fragile relationship. Having access to families had been seen as ‘an opportunity for surveillance’, with nurses expected to take on an additional social work role, reporting on cases that they felt were high risk.

The effect of this could be to breed an ‘atmosphere of fear’ and ‘erode an already fragile trust’, denying these women a valuable source of support.

One-to-one interviews with public health nurses who worked with this group of women revealed problems with engagement: women were tending to withdraw from contact with nurses, for fear of having their children removed.

This failure to keep appointments was being blamed on their engagement with drugs and the notion of their ‘chaotic lives’, rather than ‘the cycle of fear and mistrust that had been created’.

The consistent issue to be highlighted was lack of training; many of the nurses had only had child protection as a training route to deal with these issues and thought they only needed to know about the names of drugs. This gave them perceptions such as: ‘addiction results in a loss of control and affects the ability to parent properly’; and ‘recovery is equated with abstinence’ – so any continued use signalled danger to them.

Hammond relayed some typical comments from the interviews with nurses: ‘The drug use takes over – that’s all they think about,’ and ‘They want to stop it but they can’t – the pull is just too strong.’ Children were also still deemed to be at risk when they were not actually present during drug-taking, and had been left with family members. ‘Nurses still thought [the mothers] wouldn’t manage their intoxication and it would end in chaos,’ she said.

‘Overall it was quite shocking – the belief that drug use makes you a bad mother,’ said Hammond. ‘We need to not only teach parents about risks, but also be able to facilitate some critical self-reflection that’s lacking at the moment.

‘Professional practice should reflect the evid­ence base, not political or moral frame­works,’ she said. ‘What we really need is to dismantle prohibition – but in the meantime we need to recognise that the way we’re dealing with it makes it worse.’

During the question time at the end of this session, a woman from Belfast commented: ‘I asked for help and my children were taken off me. You’re damned if you do ask for help and damned if you don’t.’

More from Hit Hot Topics in our next issue.

Safeguarding conference 2015 – playing safe

adfam conferenceAre we doing enough to protect children from their parents’ drug and alcohol use? At a recent safeguarding conference there was plenty of cause for concern, as DDN reports.

‘Graham Greene said “There is always one moment in childhood when the door opens and lets the future in.” We are responsible for opening that door,’ Joy Barlow told the Adfam/DDN Everybody’s business safeguarding conference, sharing her vision that we should refocus on the rights of the child.

The event brought together professionals with an interest in this sensitive issue and did not shy away from the challenging questions. Why were we missing signs that children were at risk? Were we aware that methadone soothing took place? How could we work more effectively with fewer resources? Why were we scared of even talking about this issue?

‘This is one of the most difficult and fraught areas of practice,’ said Barlow, who was formerly head of STRADA (Scottish Training on Drugs and Alcohol). ‘We need to incorporate respectful uncertainty,’ she said, quoting Dr Marion Brandon’s research from serious case reviews. ‘We need to demonstrate empathy and acceptance, but balance it with a healthy dose of scepticism… if the truth is not always presented to us, we have to ask why.’

Tackling safeguarding needed a fundamental shift in thinking, according to many of the day’s speakers and workshop contributors. Nic Adamson, CRI director, said drug and alcohol workers ‘often used to see it as their job to rock up and defend the client.’ But this area required a different way of working: ‘We need to learn to challenge clients’ behaviour – really challenge it,’ she said.

‘It’s a Pandora’s Box – there’s a fear in what we do,’ said one delegate, and this theme kept resurfacing, in relation to safeguarding, methadone, and the delicate issue of challenging clients and asking them difficult questions.

‘There are around 400 adult deaths involving methadone a year. Say this in the wrong room and you can be intellectually decapitated,’ said Martin Smith of Derbyshire Safeguarding Team, who brought the risks to children into sharp focus.

‘Hair testing has shown that methadone soothing is more common than we like to acknowledge,’ he said. Examples from his caseload included a child death which the mother had said was accidental, but tests had shown the child had been routinely given methadone: ‘A methadone storage box had been in place, she attended appointments, her engagement was good, there was a supportive grandmother – she gave the picture that all was OK.’ In another case, ‘a woman let a toddler ingest enough methadone to kill an adult’.

‘We lack honesty and courage as a sector – let’s not shy away from difficult challenges,’ he said. ‘It’s really hard to hear the bar is so low in certain areas… we’ve all got work to do.’

 

Pete Burkinshaw

Austerity is ‘the spoiler’ that leads to ‘the deadening hand of conflicting priorities’, Pete Burkinshaw PHE

 

 

 

 

 

Rachael Evans, policy and research officer at Adfam, brought evidence from case reviews that the charity had examined to produce the new report, Medications in drug treatment: tackling the risks to children – one year on. The main findings confirmed that there was insufficient appreciation of the dangers of OST by parents and professionals, and critical issues around safe storage. Practitioners were struggling to accept the idea of intentional administration of OST and felt that having these conversations might risk disengagement.

‘We’re so busy we forget to ask the right questions,’ commented Sue Smith, CRI’s national safeguarding lead. ‘But we need to challenge… it’s our role.’

‘I was bemused and shocked that my staff used to struggle around asking about safeguarding,’ said Birmingham commissioning manager, Max Vaughan. But, he added, ‘the combination of policing and being supportive can be really difficult.’ It was about confidence, suggested one delegate, adding ‘It shocks me that other agencies say “how do we ask those questions?” You just do. You have to.’

So apart from asking the right questions – about drug and alcohol use, drug storage, and making sure that risks to children were minimised – what were the key areas for improvement? Better engagement between all of the professional partners involved with the family came high on the list.

In Birmingham, the safeguarding structure involved team leaders, who had been fully trained in safeguarding , providing real-time updates to social workers, explained Micky Browne, CRI’s safeguarding lead. The Multi-Agency Safeguarding Hub (MASH) not only improved collaborative practice, but it also reduced inappropriate referrals, he said. ‘The better agencies work together, the more efficiency will develop in the long term.’

 

Joy Barlow, Sue Smith, Martinn Smith, Carole Sharma and Judith Yates

 

 

‘This is one of the most difficult and fraught areas of practice.’ Joy Barlow (below left), pictured with (clockwise) Sue Smith, Max Vaughan, Martin Smith, Carole Sharma and Judith Yates.

 

DS Steve Rudd, of Birmingham police, added: ‘When we sit round the Mash table now, we look a what’s happening – do police actually need to run off and lock mum and dad up? In multi-agency working we all come from a different angle. We’ve developed an under­standing of where we’re all coming from and issues are very quickly resolved.’

Exchanging data that was easy to comprehend was key to creating multi-agency risk assessments, said Sue Smith. Joy Barlow believed that we needed to overturn our culture of ‘educating in silos’, bringing drug and alcohol content to social work courses. ‘You’ve got to get people together in terms of learning and development,’ she said.

The Federation of Drug and Alcohol Professionals (FDAP) were working with Adfam to develop standards and identify competencies that people working with families should all have, said FDAP’s chief executive, Carole Sharma, who added: ‘This sector has been guilty of generating mystique around ourselves. We need to undo this.’

Dr Judith Yates was hopeful that Adfam’s new report would provide focus and remind commissioners of their power to make a difference.

‘I remember the Hidden Harm report landing on my desk and it’s stayed with me,’ she said. ‘Four years ago health visitors hadn’t had training on alcohol. I hope Adfam’s report will encourage people, including pharmacists, to talk to each other.’

Inevitably the question of diminishing resources came up throughout the day, and PHE’s Pete Burkinshaw describ­ed austerity as ‘the spoiler’ that led to ‘the deadening hand of conflicting priorities’. But Martin Smith urged delegates to remember that ‘profit should never come before the needs of children’.

‘We’ve got to have courage and honesty – and we’ve got to find evidence to back up what we’re trying to change,’ he said.

Among the challenging questions fired at the panel during the final session was the issue of whether child­ren should be trained and support­ed to administer naloxone to their parent in the event of an overdose. Should they be given that responsibility?

While Dr Judith Yates was among campaigners who had welcomed the recent extension of naloxone prescrib­ing, she was worried about ‘children having to parent their parent’: ‘It depends on the age of the child,’ she said. ‘There’s something not right about a six-year-old being entrusted to save a life.’

Martin Smith said the level of responsibility was too high, while Max Vaughan agreed ‘it doesn’t feel safe or right’. Sue Smith said that it shouldn’t be entrusted to a child ‘at this stage’. But several delegates threw back a challenge of double standards, referring to the ‘stigma of this client group’.

Vivian Evans

‘Workers in this field have passion and commitment, it’s harder than rocket science.Vivienne Evans, Adfam.

 

 

 

 

 

‘Many children are left to manage chaotic drug use who haven’t had proper support,’ said one. ‘Children, whether we like it or not, are managing their parents’ drug use. We’re guilty of double standards.’

At the beginning of the day, Joy Barlow had said: ‘I’m elated at what we’ve achieved and also severely disappointed at what we’ve achieved’ in this area of practice. Adfam’s chief executive, Vivienne Evans, finished on an optimistic note by saying that workers in this field had passion and commitment, which was ‘harder than rocket science’.

‘This is hugely complex and difficult work,’ she said. ‘We need to have that optimism that we can give children the best start.’

 

Ian Day

 

 

 

 

 

‘I was spotted, supported and encouraged,’ Ian Day.

 

 

 

In an emotional speech to the main conference, Ian Day looked back to 12 years ago when he was ‘deeply entrenched in addiction’. When his partner became pregnant he made a decision to be ‘a great dad’ – but nine months later he was in prison. ‘We slipped through the social services net,’ he said. ‘They had to be the enemy. But we were difficult people to work with.’

With his daughter taken into care he had spells of homelessness before being introduced to treatment service by an old friend, who was in treatment now herself and ‘looked good’. This is where ‘interventions came into play… it was a small window of opportunity to help a person. I was spotted, supported and encouraged’.

Six months out of treatment, he approached social services to try to win custody of his daughter who had been taken into foster care. He was ‘not, on paper, the person you’d give custody of a child to’ – ‘at that time the reaction was “you’re male”, I had nowhere to live and I hadn’t seen my five-year-old for three years. So I had to prove I could be that person.’

Securing a flat took two years, during which time he was tested continually by the agencies involved.

‘I had to see my daughter in a room with a person taking notes – I was very nervous,’ he said. ‘I got enrolled on courses and at the time it felt very demeaning – they asked very obvious questions. It was very frustrating, but looking back it was the right thing because of my previous history.’

With ‘all of the agencies speaking to each other throughout’ he had his day in court and won custody. Now settled with his daughter and current partner of six years, he says he is grateful for the ‘safe environment’ created by agencies working in partnership, which led him to an outcome he never dreamed possible.

A grim picture

Adfam’s new report shows children are still dying after ingesting medications used to treat drug addiction. Its author Rachael Evans, Adfam’s policy and research officer, shares findings

Adfam has particularly focused on safeguarding over the past couple of years. Publishing our new report Medications in drug treatment: tackling the risks to children – one year on, our research revealed that far more children than previously thought are dying and being hospitalised after ingesting medications prescribed to treat their parents’ drug addiction.

 

Rachael Evans

 

 

 

 

‘Specialist workers and midwives help a service maintain a whole-family focus.’ Rachael Evans, Adfam

 

 

In the ten years to 2013, at least 110 children and teenagers aged 18 and under in the UK died from the toxic effects of OST medications. In the same time, at least 328 children in England were hospitalised and diagnosed with methadone poisoning. Of the 73 deaths in England and Wales, only seven resulted in serious case reviews (SCRs).

Since Adfam first reported on this tragic phenomenon in 2014, these cases have continued to happen, with at least three new SCRs in the last year. While many children will have consumed the medications accidentally, some were given them by their parents in a misguided attempt to help soothe or send them to sleep. The statistics also show the majority of fatal poisonings involve older, rather than younger children – but little is known about how or why these incidents occur.

OST is proven to reduce dependence on street heroin, and by doing so it saves lives, improves health and wellbeing and cuts crime. The rightful place of these medications in addiction treatment is not at issue, but it’s imperative that the risks they pose to children are better addressed and future incidents prevented.

Our report makes a number of recommendations to help do this, starting with the need for all incidents involving a child’s ingestion of these medications to be fully investigated and recorded – and analysed centrally by government, with the learning shared with local services. The wide range of professionals who come into contact with parents and carers prescribed OST medications must all be trained about their potential harm to children, and services must work together and share information more effectively to minimise risk. Parents must also be educated about the potentially fatal risk posed by OST medications, and given a secure box to store them.

Vivienne Evans, Adfam’s chief executive, said: ‘The lessons from previous tragic cases have not been heeded, and a year after we called attention to the issue, children are still dying. The vast majority of parents prescribed these medications will use them safely and appropriately – but the number of children now identified as having been harmed lends the issue even greater urgency. Systemic and cultural failure means services are still not working closely enough to safeguard vulnerable children.’

Our research, along with the training we have delivered to local authorities, has identified some areas of good practice. One drug treatment service has appointed two specialist family workers to work with pregnant service users and families. Specialist workers and midwives can help a service maintain a whole-family focus, and this model was praised by SCR panels.

Another promising model is the development of inter-agency joint protocols between drug services and health visiting teams, so that information is shared and joint home visits can be conducted. More information and examples of good practice can be found throughout the report.

AdfamBy the end of 2015, Adfam will have trained 19 local councils to reduce the risks to children posed by these medications, and we hope to continue this crucial work in 2016.

 

December 2015

IDDN Dec 2015n this month’s issue of DDN…

What’s in store?

Continuing to deliver what has worked and overcoming the deficits will become increasingly challenging over the next four years, as the cumulative 20 per cent real terms reduction in the public health grant, announced in the spending review, removes the stability of investment that underpinned 2010,’ says Paul Hayes, speaking on behalf of the Collective Voice project, in our new issue DDN.

Not only does the sector need to ‘collectively and realistically assess what can be delivered’; it needs to work out ‘how best to champion an agenda that is not a natural priority for most of the individuals and institutions responsible for its funding and delivery,’ he says.

Send us your views!

PDF Version / Virtual Magazine

Cold caller

Chris RobinA craving is the salesperson we can choose to ignore, says Chris Robin

It’s a fact that a craving has to strike before a person uses drugs or alcohol, and that’s why they can be terrifying for service users. A common technique in dealing with cravings is to distract the individual from their desire to ‘use’. Yet, if someone avoids something the result is often a sense of fear, and from fear comes powerlessness. The substance user must be able to face their fear!

A craving is like a salesperson. Its purpose is to sell the thought of using to the customer and make it look attractive. It sells the idea of pleasure and euphoria.

It doesn’t talk about comedowns, or any other side effects, as that information would get in the way of the pleasure. The salesperson reminds the customer that if they use the product, it will change the way they view the world immediately, and that they will be stress and problem free.

In the break-up of a relationship, even if the decision to part was the right one, the parties will continue to yearn for one another, and the loss they experience will be extreme. This could be said of the service user’s relationship with substances, as they will miss their drug of choice and experience longing and desire as well as grief for the loss. Cravings – the salesperson – will fully understand this and will know how to target those feelings, either blatantly or silently, to keep selling the product.

When we help service users to look at their relationship with a drug, it is important to acknowledge the yearning they may experience and the grieving process they are going through. Rather than distract them from these feelings, give them permission to be honest about the craving, so they can be aware of the sales pitch that is being used on them. This recognition will then inform the craving that it has been exposed, so it will have to become less blatant, more subtle, more silent, more devious, to make the sale. Again the worker’s job is to help the service user to investigate these devious cravings so they can understand their sophistication.

Equipped with this information, the service user then has the tools to communicate with their cravings, stand up to them and say: ‘I see you, I know your agenda, and I am no longer afraid of you!’

Chris Robin offers treatment and training at Janus Solutions, www.janussolutions.co.uk

First impressions

Shahroo IzadiThe pressure to collect data from new clients should not replace essential rapport, says Shahroo Izadi

Emerging Horizons’ facilitators often begin training by asking delegates to describe why they do the job they do. Answers rarely deviate from themes such as being naturally engaging, an ability to build rapport, strengths in communicating empathy and a genuine desire to help.

These qualities are at the very heart of conducting an effective assessment, one that begins the non-judgemental process of supporting individuals to establish values, uncover strengths and build upon them.

Frequently, however, staff report that the rushed box ticking, contract signing and form filling required at first point of contact has become professionally debilitating. It seems widely accepted that therapeutic intervention begins during the second appointment (provided the client has come back).

Despite positive improvements across the substance misuse sector, it seemingly remains widely acknowledged that traditional health and social care assessments are too focused on deficits and inadequacies, with some practitioners expressing concerns that their deficit-based assessment procedures may actually disempower and intimidate those who have found the courage to seek their help. Given the space to reflect, delegates often also realise how commonplace it has become for this crucial first meeting to be facilitated in a room ‘decorated’ exclusively in posters threatening certain death from overdose, HIV and hepatitis, often precariously tacked next to greyscale warnings of the latest bad batch of heroin in local circulation.

Workers often report feeling pressured to hurriedly collect meaningful and reliable data on highly personal experiences such as sex working, abuse and illegal behaviour. Some staff have admitted during training that it was not until they had built rapport with their clients that they realised how much of the information collected at point of assessment was inaccurate.

Assessment protocols need to be systematically reviewed, updated and facilitated in a welcoming environment that models recovery. The paperwork should be designed as a tool to assist practitioners in collaborating with their clients on the development of a strength-based, person-centred recovery plan. For this to happen, even essential data capturing needs to be concise, accessible and client-led, as well as designed to focus on establishing recovery capital in areas such as relationships, social pursuits and life purpose.

Shahroo Izadi is development manager at Emerging Horizons, www.emerginghorizons.org

Bucking the trend

Josie Smith Chris EmmersonUnlike in England, drug deaths in Wales have been falling since 2010 – a result that can be traced to Welsh public health policy and harm reduction practice, say Josie Smith and Chris Emmerson 

 

As previously reported in DDN (October, page 4), according to data from the Office for National Statistics (ONS), a total of 2,248 deaths from drug misuse were registered in England and Wales in 2014 – a rise of 14.9 per cent on 2013.

Building on the near 20 per cent increase in drug misuse deaths from the previous year, a notable change in the pattern of drug deaths seemed to be emerging.

However, this paints an inaccurate picture. While drug misuse deaths in England have risen dramatically over the last two years, drug deaths in Wales have fallen year-on-year since 2010, with a 30 per cent decrease in the last five years to a total of 113 deaths – a rate of 3.90 per 100,000 population.

With drug misuse deaths in England now at their highest level over the 22 years for which the ONS publishes figures, the need for credible explanations for the rise became urgent.

One set of explanations has focused on changes to drugs and those who use them. The ONS, in the statistical bulletin accompanying the release of the 2014 figures, points to changes in the purity of street heroin (as reported by SOCA, the UK’s Serious Organised Crime Agency) as a possible influence on variations in drug deaths over recent years. Sustained rises in reported purity coincided with increases in deaths involving heroin/morphine in England. The ONS also suggests that, with increasing numbers of deaths among older drug users, the generation who began injecting in the 1980s and 1990s are aging and therefore at higher risk of dying from drug-related causes as other health problems take their toll.

However, the same ONS report provides another key piece of information that challenges the focus on changes to drugs and this demographic of drug users as key reasons for rising drug deaths. It comes on page 19: ‘…whilst drug-related deaths in England have now reached an all time high, those in Wales have fallen over the same period, down 16.3 per cent in 2014 to 113. Indeed, the rate of drug misuse deaths across the Welsh population, at 39 per million, is now less than England for the first time since 2004.’

With no reason to believe that either heroin markets or drug-using careers in Wales are substantially different to England, how can we explain the difference?

The second narrative to emerge following the release of the figures is that the difference is down to policy and philosophy. With health policy devolved within the UK, it is the Welsh Government that decides the priorities for substance misuse in Wales. In contrast to England, where – as reported in last month’s article on the National Needle Exchange Forum meeting (DDN, October, page 16) – many users, frontline staff and managers are finding reduced funding and support for well-evidenced harm reduction approaches in favour of abstinence based ‘recovery’ models, Wales has maintained focus and funding for harm reduction.

In response to the release of the 2014 figures, deputy minister for health Vaughan Gething said, ‘These figures represent lives lost to families and communities across Wales and while I welcome the news of a further decrease, any death attributable to drugs is one too many.

‘Tackling drug misuse is a complex issue, which the Welsh Government has been working hard to address. The fact that drug-related deaths are falling at such a rate in Wales is testament to the significant work, which we and our partners are undertaking.

‘We are investing almost £50m a year in programmes including a bilingual substance misuse helpline, a take-home naloxone programme which reverses opiate overdose and the WEDINOS harm reduction project which tests substances. These figures show that this money is delivering tangible benefits.’

Also commenting on the figures, Josie Smith said, ‘It is a testament to the National Substance Misuse Strategy in Wales, Working together to reduce harm, ongoing support for harm reduction services and a willingness to innovate new approaches to reduce risk, that have resulted in fewer drug deaths in Wales. Problematic drug use in Wales remains but the most severe of consequences, that of premature death, is declining through better engagement, appropriate and evidence-informed interventions and collaborative working.’

Josie Smith is head of substance misuse programme and Chris Emmerson is information analyst specialist at Public Health Wales

The state we’re in

Erin O'Mara

Forcing stable people off their heroin scripts and into chaos is evidence of a British drug treatment system in terminal decline, says Erin O’Mara

‘I feel like they are waiting for the last handful of us to die off and that will be the end of heroin prescribing in Britain, as we know it’, I said miserably.

Gary Sutton, Release’s head of drugs services, turned and looked at me seriously through his spectacles: ‘If we don’t try and do something now there will be no diamorphine prescribing left anywhere in the UK.’

Gary tapped away on the computer in front of me, putting the last few lines on a letter to yet another treatment service who had been forcibly extracting a long-term client off his diamorphine ampoules and onto an oral medication. It was proving to be a painful and destructive decision for the client, who was experiencing a new daily torment as his once stable life began to unravel around him.

The drug team and its helpline (known affectionately as ‘Narco’), all part of the UK charity Release, receives phone calls from people in drug treatment from all over the UK. By doing so it serves as the proverbial stethoscope clamped to the arrhythmic heart of our nation’s drug politik and bears witness to the fallout from Number 10 affecting the individual, on the street and in treatment. In other words, we witness the consequences of policy and treatment decisions, and try to support or advocate for the caller.

But as winter draws the shades on yet another year in the drugs field, we find we are bearing witness to a tragedy, one of small proportions but with huge implications. It involves the last vestiges of the British system of drug treatment, the ‘jewel in its crown’ – heroin prescribing – and the decline of the NHS, under assault from a mercilessly competitive tendering process and the crude procurement that is defining its replacement. Is that where we are really heading?

It may be true to say that to try to define the old ‘British system’ is to trap its wings under a microscope and allow for a possibly contentious dissection; the late ‘Bing’ Spear, formerly chief inspector of the Home Office drugs branch, might be first in line by reminding us that the implications of ‘“system” and “programme” suggests a coordination, order and an element of (state) planning and direction, all totally alien to the fundamental ethos of the British approach, which is to allow doctors to practise medicine with minimal bureaucratic interference’. His point being that the essence of the ‘British system’ was that it ‘allows the individual doctor total clinical freedom to decide how to treat an addict patient’.

John Strang and Michael Gossop, in their thoroughly researched double volume book Heroin Addiction and the British System, stated in the epilogue of volume two, that ‘amongst the (probably unintended) benefits of [this] approach may be the avoidance of the pursuit of extreme solutions and hence an ability to tolerate imperfection, alongside a greater freedom, and hence a particular capacity for evolution.’

The British ‘approach’ (as may arguably be a more appropriate phrase to use) had once allowed for a level of evolution; of experimentation and pharmaceutical flexibility; three characteristics that are glaringly missing from frontline drug treatment today. Although we have no room to discuss clinical guidance here, it is often the case that when presenting services with complex individual cases at Release, we are rebuffed by the response ‘it’s not in the guidelines’, ‘it’s not licensed’, or even, as if drug workers are loyal party backbenchers, ’it’s not government policy’!

Hindsight is a gift, and although many of us could while away the hours pontificating about just how and why it all went so publically wrong for our ‘unhindered prescribers’ back in the day (think Drs Petro, (Lady) Frankau, and a handful of others), that would be to miss the point. The reality is, once we pick up and examine the pieces of the last 100 years, there are shining areas of light in our British approach. Marked by both a simple humanity and a brilliant audacity, it permitted a private and dignified discussion between doctor and patient to find the drug that created the preconditions for the ‘patient’ (today the ‘client’) to find the necessary balance in life.

Are we really back to the days of having to ask to be treated as an individual? Policy is now interfering in treatment to such an extent that the formulation that the patient feels works best for them (physeptone tablets, heroin, morphine, oxycodone, DF118s etc) may no longer fit into today’s homogenous and fixated theme of methadone or buprenorphine, one part of a backwards step.

The days when heroin prescribing was defended as tenaciously as a doctor’s right to prescribe unhindered are almost gone. Fear and public ignorance have forced us to collapse any new diamorphine prescribing into a tight wad of supervision, medicalisation and regulation while prohibition, politics and the soundbite media have meant that we have been doomed to discuss this subject under the umbrella of ‘treating the most intractable, the most damaged, the treatment failures, the failures of treatment’.

Why must a treatment that has proven to be the optimum for so many people be left until people had been forced to suffer through a series of personal disasters and treatment failures? Did this narrative help to diminish the intervention?

The last few dozen people left on take home diamorphine prescriptions in the UK today seem to be stable, functioning, often working people who no longer have so much a ‘drug problem’ as a manageable drug dependence. This last group of diamorphine clients are remnants of the old system with, it appears, no new people taking their places once they leave. Today these are some of the very people who are now ringing the Release helpline to try to save their prescriptions altogether. They are frightened, most of them are in their fifties and had qualified for diamorphine many years ago because ‘nothing else worked’; what now are they to do?

Diamorphine prescribing has been ensconced in a political and clinical debate about the expense and fears of an imaginary tsunami of diversion. Yet what of today’s financial wastage? We have ways to deal with diversion, yet poor and frequent commissioning has a number of serious consequences, including a lack of continuity of care, a slide back to postcode variance and, not least, cost. An exercise to quantify the costs of tendering services more than ten years ago came up with a figure of £300,000 as the sum expended by all bidders and the commissioner, per tender – money that could be better spent, surely?

A few weeks ago the LSE put on a mini-symposium on diamorphine with a panel of international clinicians, academics and research experts. Everyone present agreed that prescribing diamorphine, albeit in a very controlled, supervised manner, had tremendous merit. Taking the idea from the success in Britain (eg Dr John Marks), today we see a method that has evolved across Europe; the Swiss, the Dutch, the Germans and the Danes, among others are all doing it – treating thousands of clients and with great results. So it was more than frustrating to hear that our own diamorphine clinical trials had been closed this year with no plans to restart them.

Diamorphine should not end up marginalised and discarded because a controversial new ‘system’ finds it far harder to tolerate than the patients who receive it do.

The benefit is proven. It’s not a choice between maintenance and abstinence. Addiction is not reductive to either/or and, as treatment is neither just a science nor an art, clinicians should not be restricted to methadone or subutex, or our clients subjected to a binary ‘take it or leave it’ choice in services.

Erin O’Mara is editor of Black Poppy mag­azine and is currently volunteering at Release

 

Medications in drug treatment: tackling the risks to children

Vivian EvansOST and children: lessons still ‘not heeded’, says Adfam

More children than previously thought are dying or being hospitalised after ingesting opioid substitution therapy (OST) medications, according to a new report from Adfam. The document is a follow-up to the charity’s hard-hitting Medications in drug treatment: tackling the risks to children report from last year, which found that the safeguarding of children was not being sufficiently prioritised (DDN, May 2014, page 4). The lessons from previous tragic cases have still not been learned, the charity says.

While the first report identified 23 incidents of ingestion and 17 child deaths in the decade to 2013, mortality and hospitalisation data uncovered since reveal a far more serious situation, with 110 children and teenagers under 18 dying as a result of ingesting OST medicines over that period and at least 328 diagnosed with methadone poisoning after being hospitalised. ‘The new statistics are shocking,’ says the document, stressing that they add ‘weight and urgency’ to the issue. There have also been at least three more serious case reviews since the publication of the last report, Adfam points out.

The charity wants to see all incidents of children ingesting OST medication ‘fully investigated and recorded’, with the information properly analysed and shared with local services. Although many incidences result from accidental ingestion, in some cases the medications are deliberately administered by parents ‘in a misguided attempt’ to help soothe or send children to sleep, it says. Adfam is calling for proper training for parents as well as for all professionals who come into contact with parents and carers prescribed OST drugs.

‘The lessons from previous tragic cases have not been heeded, and a year after we called attention to the issue, children are still dying,’ said Adfam chief executive Vivienne Evans. ‘The vast majority of parents prescribed these medications will use them safely and appropriately – but the number of children now identified as having been harmed lends the issue even greater urgency. Systemic and cultural failure means services are still not working closely enough to safeguard vulnerable children.’

Medications in drug treatment: tackling the risks to children – one year on at www.adfam.org.uk

Safeguarding in Treatment – feedback form

[contact-form-7 id=”12854″ title=”Safeguarding in Treatment – feedback”]

Treatment threatened by constant re-procurement, warns ACMD

Annette Dale PereraThe quality of treatment for heroin users is being threatened by diminishing funds and ‘disruptive re-procurement processes’, according to a new report from the Advisory Council on the Misuse of Drugs (ACMD).

Treatment quality now varies significantly across England, says the document, and is being further compromised by ‘frequent re-procurement and shrinking resources’. The report stresses that investment in drug treatment needs to be protected, as it is cost-effective and beneficial to society, and it calls for the implementation of a national quality improvement programme. It also wants to see more done to create a ‘culture of stability’ and reduce ‘churn’ in local systems.

The document, which also considers issues such as how to tackle low expectations of recovery, how to prioritise resources to achieve better social reintegration, and how to address misuse and diversion of OST medication, is the final of two ACMD reports into opioid substitution therapy commissioned by the Inter-Ministerial Group on Drugs. The first, published late last year, firmly rejected the idea of time limits on substitution treatment (DDN, December 2014, page 4).

‘Everyone with heroin dependency should have access to high-quality drug treatment,’ the document states, expressing concerns about lack of progress on helping people ‘achieve employability’. More effort is required to achieve this, it says, including vocational training, supported work placements and ‘targeted employment schemes’, including tackling stigma among employers.

However, a ‘significant number’ of heroin users new to treatment appear to be able to complete that treatment and not return, it stresses, particularly if they ‘stop using heroin within six months of starting OST’. Those who are stable and remain in OST for more than five years or more, meanwhile, should ‘be positively regarded as in “medication-assisted recovery”,’ which should ‘not hinder access to healthcare interventions, peer-led recovery interventions and social integration’. This group should not be discriminated against simply because they are in OST, the report warns.

‘Government has done well to achieve widespread recovery-orientated drug treatment for heroin users,’ said co-chair of the ACMD’s recovery committee Annette Dale-Perera. ‘Treatment protects against drug-related death, ill health, chaos caused by addiction, and crime and can help people turn their lives around. We need to act to improve, and not lose, this valuable asset to society.’

How can opioid substitution therapy (and drug treatment and recovery systems) be optimised to maximise recovery outcomes for service users? at www.gov.uk

Local news from the substance misuse field

Addiction charity wins excellence awards

Phoenix Futures has been awarded two UK excellence awards for leadership and customer satisfaction by the British Quality Foundation (BQF).

BQF awardsThe awards recognise organisations that have demonstrated excellence in all areas of operation. To become a finalist, Phoenix had to be recommended by assessors who visited their services earlier this year, and former resident Lawrence Smith shared his personal story with the BQF panel as part of their entry.

Phoenix staff received their awards from businesswoman and star of The Apprentice Baroness Karren Brady CBE at a recent black-tie event.

‘The most incredible part of winning these two awards for leadership and customer satisfaction is that every single staff member and volunteer can feel proud that they helped contribute to Phoenix’s success,’ said chief executive Karen Biggs.

 

RoRLaunch event celebrates new recovery service

Reach Out Recovery (ROR), a drug and alcohol recovery service in Birmingham, has recently celebrated the opening of its new service.

The facility, which opened in March, offers an holistic approach and supports people within their own communities by offering life skills such as finding a job and rebuilding past relationships.

CRI’s executive director Mark Moody and director Nic Adamson opened the launch event, which was attended by staff, service users and representatives from local services and communities.

The event included presentations and workshops, highlighting the support being offered and sharing success stories from the service.

 

Forward LeedsDrug and alcohol advice offered to students

Staff from Forward Leeds have been educating university students about drugs and alcohol misuse at freshers’ events across the city.

Students had the chance to take part in activities such as ‘beer goggle darts’, while being given advice on understanding the effects of different drugs and alcohol and how to remain safe.

‘We’d like to get students thinking about the risk factors around drinking and drug taking. We want them to stay safe,’ said Jane Doyle, early intervention and prevention lead practitioner.

 

Programme for ex-servicemen receives funding

The Forces in Mind Trust (FiMT) has awarded a grant to Edinburgh-based charity Venture Trust to fund the Positive Futures project, which will support ex-servicemen and women across Scotland who are struggling to adapt to civilian life.

The programme will offer participants support in three stages – advice on employ­ment, personal development and referral to services where needed; a personal develop­ment programme and one-to-one and group support sessions; and ongoing support focused on internships, employment and peer mentoring to help individuals move forward with their lives.

 

Tea roomsRecovery house offers better access to support

A new recovery house has been opened in Staffordshire for those who have completed rehabilitation and want to return to their home area.

The centre will help people access support, short-term accommodation, and education and skills training, as well as engaging families in the recovery process. Langan’s tea rooms, a social enterprise, will also offer volunteering and employment opportunities.

The house was opened by Secretary of State Iain Duncan Smith and representatives from Burton Addiction Centre, Cannock Chase District Council and Staffordshire County Council.

 

News beginningsPeer mentors gain full-time employment  

Two ex service users have begun new careers as support workers after graduating from a peer-mentoring scheme in Doncaster.

Daniel Bowden and Joe Sheerin were both supported by Doncaster’s Drug and Alcohol Services during their recovery, and became volunteer peer mentors to help others on similar journeys. Both men went through a rigorous interview process for their new roles – Daniel at the Alcohol and Drug Service (ADS), and Joe at New Beginnings drug and alcohol rehabilitation centre.

‘By sharing their own experiences, peer mentors deliver vital support to people beginning their recovery journeys,’ said volunteer and mentor coordinator Lydia Rice. ‘They offer empathy and encouragement, and play a valuable role in motivating others.’

 

National news from the substance misuse field

BRIEF BRIEFING

‘Decisive’ coordinated action is needed to ensure a future for alcohol brief interventions, according to a report from the Alcohol Academy and Alcohol Research UK. Alcohol identification and brief advice (IBA) has proved difficult to implement effectively, says the document, with ongoing issues around primary care as the key setting and ‘understanding what brief intervention actually involves’. Alcohol brief intervention: where next for IBA? at alcoholresearchuk.org

 

SEIZURE STATS

The number of drug seizures in England and Wales fell by 14 per cent in 2014-15 to just over 167,000, according to figures from the Home Office. More than 124,000 of these were seizures of cannabis – down by 17 per cent on the previous year. Overall class A seizures were also down by 10 per cent, despite seizures of heroin increasing by more than 70 per cent. Seizures of drugs in England and Wales, 2014/15 at www.gov.uk

 

HELP IN SIGHT

The first guide to substance use and sight loss has been published by the Thomas Pocklington Trust, and includes key resources for professionals and best practice examples. ‘Our research found that both sight loss and substance abuse services are not adequately equipped to deal with these overlapping issues,’ said lead author Sarah Galvani. ‘Substance abuse can sometimes be used as a coping mechanism for sight loss, but the combination of both issues can create a complex challenge for support professionals.’ Substance use and sight loss at alcoholresearchuk.org

 

SAFEGUARDING ACTIONsafeguarding

More children than previously thought are dying or being hospitalised after ingesting opioid substitution therapy (OST) medications, according to a new report from Adfam. The charity says lessons from previous tragic cases have still not been learned and wants to see all incidents of children ingesting OST medication ‘fully investigated and recorded’, with the information properly analysed and shared with local services. Adfam is calling for proper training for parents as well as for all professionals who come into contact with parents and carers prescribed OST drugs.

Medications in drug treatment: tackling the risks to children – one year on at www.adfam.org.uk

See feature, page 12

 

HELPING CHILDREN TALK ABOUT PARENTS’ TREATMENT

Joanna ManningA new resource booklet has been produced by The Children’s Society to help young people affected by a parent or carer’s alcohol or drug treatment.

Help me understand aims to encourage ten to 14-year-olds to talk to support workers and has been designed to communicate simply and directly, including messages from others in the same situation.

‘While having a parent or carer in treatment can be a positive thing, it can also be very confusing and distressing,’ said Joanna Manning, national lead on substance misuse at The Children’s Society. ‘[This] will be a valuable tool for workers to use in helping children and young people to stay safe and to understand the importance of accepting and sharing their feelings.’

The booklet was launched at Adfam/DDN’s safeguarding conference Everybody’s business, held in Birmingham.

Available to download at www.starsnationalinitiative.org.uk

 

 

Comment from the substance misuse sector

Letters

Letters and comments

DDN welcomes your Letters Please email the editor, claire@cjwellings.com, or post them to DDN, CJ Wellings Ltd, 57 High Street, Ashford, Kent TN24 8SG. Letters may be edited for space or clarity.

No offence

Although we feel strongly about the subject of our letter (DDN, October, page 8), on reflection some of the language used was perhaps inappropriate and we apologise to those concerned. In particular we in no way wanted to offend Mr Marteau, who has worked tirelessly in this area for decades and helped to improve care for those with addiction problems.

Dr Chris Ford, Dr Clare Gerada, Dr Euan Lawson et al

Just to clarify

Dear Chris and all, I am grateful for your generous words. To clarify your letter’s point about France, the French treatment system as a whole now has 70 per cent of OST patients treated with buprenorphine, 30 per cent with methadone. The latest French drug-related deaths and OST data (OFDT, 2014) indicate that methadone was seven times more dangerous than buprenorphine in 2012.

If we are to retain methadone as first line, it is incumbent on us to demonstrate that methadone is several times more effective than buprenorphine at keeping the population alive. If it is not, and I have deep concern that this is the case, then we are in the realm of avoidable deaths.

Dave Marteau

Dangerous words

In a climate where those undergoing treatment with methadone are increasingly finding themselves on the end of daily supervised consumption, I found the letter ‘Marteau complex’ signed by Dr Chris Ford et al in last months DDN, which seemed to condone diversion, wholly unhelpful.

It may be OK stating this as a ‘what if?’ academic flight of fancy, but when you’re a service user facing an increasingly punitive drug treatment system, this kind of statement merely provides more ammunition for those voices against OST and methadone in particular.

Peter Simonson, London

Misleading stats?

I am writing to express my disappointment at the way in which the drug poisoning deaths in England and Wales were portrayed in your article (DDN, October, page 4).

The article as written suggests that drug poisoning deaths have risen in Wales as well as England. This is clearly not the case.

In 2014 there were 168 drug poisoning deaths in Wales, a decrease of 40 (19 per cent) compared with 2013, and the lowest since 2008.

Gareth Hewitt, head of substance misuse policy and finance, Welsh Government

DDN responds: Our news story does state in the third paragraph, ‘While England saw a 17 per cent increase in its drug misuse mortality rate… Wales saw its proportion drop by 16 per cent to 39.0 per million, the lowest figure for almost a decade.’ The reference to England and Wales registering the highest number of deaths reflects the ONS reporting region.

Drug and alcohol in the news

Media savvyMedia savvy

The news and views from the national media

If the Lib Dems have any function now, it’s on issues such as drug decriminalisation, child detention, prison reform, surveillance: civil liberties. With Jeremy Corbyn’s Labour we have a puritanical left where personal freedom is less important than some holier-than-thou posturing. The hair shirt opposite of Theresa May’s nastiness… We could do with a party that believes in personal freedom. It’s a shame it’s led by the semi-vicarish Tim Farron, but if they can puncture some of the hypocrisy on drug laws, good for them. This is hardly radical, just sensible.

Suzanne Moore, Guardian, 12 October

Had the e-cigarette been invented and patented by a pharmaceutical company and promoted by the government, it would have failed. Big Pharma would have called the device Niquo-Stop453, made it from plastic, packaged it in boring green and white and sold it in chemists’ shops. No bureaucrat or corporate lackey would have thought, ‘What if we call it Unicorn Puke and sell it like a high-end electrical product?’ To smokers, switching to Niquo-Stop453 would have felt like a sad compromise: like being treated for a disease. Switching to Unicorn Puke feels like a choice.

Rory Sutherland, Spectator, 24 October

Whatever alcohol companies do to fight back against the declining popularity of booze, deep changes in British culture have made booze less attractive. Forget the horrific tales of drunken escapades from Magaluf to the Bullingdon Club. The real story is of the strange death of boozy Britain.

Tim Wigmore, New Statesman, 9 October

There is a contradiction at the heart of the policy agenda, where a rhetorical commitment to patient choice turns out to be fatally compromised by a paternalism that the health service claims to have abandoned. Patronising people and protecting them from themselves just won’t wash anymore. If we choose to smoke or vape, or drink or eat too much, that should be up to us.

Dave Clements, Guardian, 1 October

A balanced assessment of the evidence, rather than the ideology, surely is the best guide to policy. For my own part, a softening of the legislation on drug use (coupled, of course, with access to medical treatment), combined with a hardening of social attitudes against it appears the most fruitful way forward.

Hamish McRae, Independent, 21 October

 

Supporting vulnerable women

Nicky GoulderTake a bow

Nicky Goulder talks about how an acting workshop is supporting vulnerable women in east London

For over five years, arts charity Create has helped vulnerable women in east London make steps to reshape their lives through the creative arts. In collaboration with international law firm Reed Smith LLP and U-Turn Women’s Project, Create’s workshops reach women of all ages who have been trapped in cycles of prostitution, drug addiction, physical abuse and homelessness from an early age.

Since July, the women have been working with Create’s professional actor and playwright James Baldwin, collaborating to write original stories and outline plots that feature a problem, a journey, an obstacle and a solution, echoing the challenges that they have experienced themselves. This has allowed them to share their experiences and expand their support networks to include other vulnerable women within their community.

Every year, women are forced into prostitution through a combination of homelessness, drug use, poverty and domestic violence, which accounted for 30 per cent of all violent crime in Tower Hamlets in 2009-10. Create uses the creative arts to inspire self-confidence in vulnerable women who attend the U-Turn centre, encouraging them to develop trust, friendships, communication skills and pride through collaborative activities. These skills and qualities can then be used in day-to-day life, helping the women reclaim control over their futures.

U TurnMargaret has a history of drug use but is currently in recovery and has been abstinent for seven years. She attended the centre initially for general support with benefits and some ongoing confidence issues, but is more confident and independent now. ‘You learn so much,’ she says of the workshops. ‘Communicating with other people that you really don’t know and things like that. A lot of my confidence went and I have just started to get my confidence back since coming here. It had been gone for years and years.’

Nicky Goulder is CEO of Create

https://www.facebook.com/create.transforming.lives

Addiction and recovery in East London

Graham MarshallThe times they are a changin’

As Spitalfields Crypt Trust (SCT) celebrates 50 years of helping people in recovery, CEO Graham Marshall looks back at the changing landscape of addiction and recovery in East London

When I was young I experimented with drugs and got into trouble. After spending a year in rehab, I started volunteering for SCT in the late ‘70s and have stayed ever since. My first job mainly involved giving sandwiches and clothing to homeless callers at the crypt, and talking to them. It was run from Christ Church Spitalfields, and we provided a supportive environment and an increasingly challenging programme for about 18 men with alcohol problems who came in straight from the streets or the local detox in Whitechapel.

The crypt was once a ‘dry house’ for homeless alcoholic men. In the early days, these were the most hardcore drinkers around. Cider, wine, methylated and surgical spirits were the most common drinks then, and in that order. This was back when Spitalfields was a big fruit and veg market, with countless places or derelict building sites where people could sleep, called ‘derries’ and ‘skippers.’

We moved our residential programme to Shoreditch where we now support 16 men, recovering from their addiction in a much more intense way than we ever could back when I started.

Back in the days of the crypt, we realised that just keeping the men warm and dry was not enough and many of them had very basic living skills. They might know how to get by on the streets, but they did not know how to ‘do life’ – find a job, a home and cook a meal for themselves. There was no aftercare. They got sober, but didn’t have a recovery programme. So we set one up, drawing heavily on the 12-step programme.

We run a personal development and training centre, and three social enterprises where individuals can learn the skills of working with people and gain experience that will give them a chance of finding a job. Much of our work is supported by our own fundraising efforts and charity shops.

I still love my work – I see positive change. It’s about people coming off dependency and recovering their sobriety, and learning to love life, themselves and others.

Graham Marshall is CEO of Spitalfields Crypt Trust. www.sct.org.uk

Literacy and drug treatment

Richard HomerThe writing’s on the wall

Literacy issues can be a barrier to participant engagement and successful outcomes in substance misuse treatment programmes. Richard Homer explores the reasons why

There’s a host of common challenges when delivering drug treatment programmes. One of the biggest is how to ensure participants understand and retain the content presented to them.

There are five persistent limitations that prevent individuals from accessing the right treatment for their level of understanding: many programmes place emphasis on written work, but classroom environments can be difficult for those with negative experiences of school and topics and terminology can confuse those who struggle to grasp the extent of their substance misuse. People with English as an additional language, meanwhile, are rarely provided for, and basic training for facilitators is sometimes missing.

With the right approach, these are preventable – even when coupled with additional factors such as poor concentration (often due to detox) and restrictive attendance criteria. However, another key limitation in many cases is the comprehension of a programme’s content. Many programmes do not allow for personal academic ability, mental health, language or cultural differences. As a result, programme content can be confusing due to the diverse way in which teaching can be delivered and learned.

Substance misuse programmes are often ‘word-heavy’, and require participants to ex­press themselves in a universal way. Govern­ment data shows that a high percent­age of individuals accessing treatment have low literacy levels and learning disabilities. Many have jumped hurdles to start a treatment programme, only to discover the material requires a level of focus, comprehen­sion or language beyond their ability

So why does this problem need to be tackled? While low literacy doesn’t necessarily lead to drug and alcohol issues, it is imperative that we address substance misuse in a way that is accessible to all abilities and learning styles. Ignoring this will result in certain groups of people falling through the cracks of the treatment system and never reaching their potential for recovery.

Richard Homer is managing director of Vivid Training www.vividtraining.co.uk

Service user involvement

The Worm coverThe worm has turned

The Worm, a new service user-led magazine recently launched in Haringey, is tackling stigma and promoting a positive image of people in recovery

Back in July 2014, a group of individuals accessing treatment at Haringey’s alcohol treatment service decided to get together and use their personal experiences to do something to address the stigma faced by those in recovery.

They settled on the idea of a magazine to promote understanding about recovery, and, slowly, a team began to form, encouraged to use the skills they already possessed. With the backing of the service staff, founding member Jac Geraghty applied for – and ultimately received – funding for the project.

The Worm was born, and after much hard work, an event – which included music, poetry readings and a film screening – was held in July at Haringey Recovery Service to launch the first issue. It has been distributed by hand to more than 70 locations including libraries and GP surgeries, both locally and nationally.

Everyone who contributes their time to the magazine receives Haringey time credits – a community currency that recognises voluntary support of other people and services, which can then be spent at a number of time credit partners. This helps the team to continue making The Worm, as they can use the time credits to rent meeting spaces or go to the cinema to review a film for the magazine.

Once the funding for the first issue has been used, the magazine aims to be self-funding, so the team are busy contacting local businesses and charities to invite them to advertise in future editions and keep the positive message going.

 

The Worm 1Founding member and editor-in-chief Jac Geraghty talks about how it all began

One day I had an idea for a magazine – and that idea was realised by extremely talented people, all of whom are in recovery.

We received funding for one issue from Haringey council’s Bright Sparks scheme. They gave us nearly £2,000, which allowed us to buy a computer and print our magazine. With this investment, we will be able to be self-sufficient in producing our upcoming issues, and the plan is to produce four a year.

We have also been greatly supported by Haringey time credits and Haringey Recovery Service – a partnership between St Mungo’s Broadway and alcohol support charity HAGA.

The idea came about during a tea break at Breaking Ground, part of the HAGA sustainment programme. It was then realised during the abstinence-based day programme, and has gone on to be a phenomenal success.

The plan behind The Worm was to hone and build on already established skills within our recovery programme. To be honest, it started out slowly, but once word spread we were inundated with ideas and contributions. We have a Facebook page, Twitter account, blog and, of course, our magazine. We are actively recruiting new members – from feature writers and researchers to sales and marketing managers.

I am extremely proud that The Worm has grown, and we are now a force of nature. The magazine is a community, and an extremely strong one at that. The Worm stands for Working to Overcome Recovery Misconceptions, and I think we are living up to that statement.

Spread the word – we are The Worm and we have arrived!

For more information, visit www.haringeyrecovery.org.uk or The Worm Facebook page, www.facebook.com/groups/790169471102851/

Recovery and drug treatment

Mark Gilman, Peter McDermott and Peter SheathTackling the deficit

Can an entrepreneurial recovery culture overtake an ailing treatment system? Mark Gilman, Peter McDermott and Peter Sheath examine the politics

‘Homophily’: the idea that if you want to stop smoking, overeating and getting divorced, you need to stop hanging around with smokers, fat people and divorcees. If you sit in the barber’s chair long enough, you’ll eventually get a haircut. If you’re seeking recovery it makes sense to hang around other recovering people.

Mutual aid groups are the obvious place to meet those people, but if you do throw yourself into recovery culture, be prepared to have pre-existing beliefs brutally challenged:

‘I’ve been thinking’

‘Stop it – your best thinking got you here.’

‘Take the cotton wool out of your ears and stuff it in your mouth. You might hear something that will save your life.’

‘Oh and get a job! Any job – it doesn’t matter what.’

Recovery narratives can sound moralistic, conservative and Conservative. Moral relativism is rare among people in long-term recovery. There are right and wrong ways of living. The right way is to get a job, pay your rent and care for your friends and family. The wrong way is methadone, booze, benzos and benefits; watching daytime TV while the state takes care of your kids.

In the aftermath of the general election we noticed something peculiar. There seemed to be a political, ontological divide between two tribes – those affiliated with the harm reduction model, and those affiliated with the recovery model. It didn’t seem to matter whether the person expressing the view worked in the field, or was in treatment/recovery themselves.

Harm reductionists saw the outcome as an attack on the entitlement to remain on long-term sickness benefits. They were supportive of a large publicly funded treatment system, which was threatened by the Tory victory.

Recovery messages were about voluntarism, about the need to take personal responsibility and building community – messages that were completely consistent with those of the Conservative government.

Despite Public Health England’s excellent facilitated access to mutual aid (FAMA) programme, few people make the journey from treatment services to mutual aid based recovery. There are exceptions to this and there is cause for optimism in those areas covered by the new grouping of commissioners for recovery who will find their collective voice via the British Addiction Recovery Group (BARG). The real problem for many community treatment service providers is that they simply cannot live with the uncertainties and risks of recovery:

‘These people – my patients, clients, service users – need me to do something. They might die if I don’t provide medical treatment.’

And of course this is true. Some patients might die if they attempt abstinence-based recovery. Life is a risky business but people with ambition and hope take these risks all over the world every day. Leaving the protection of methadone maintenance treatment may increase the risk of death. But it might also be the way to a brand new life beyond your wildest dreams, where you find jobs, homes and friends.

If successful, you might even create a firewall in the intergenerational transmission of addiction in your families. The question is, where should the responsibility for that decision lie? With the commissioner? With the service? Or with the patient themselves?

Again, this risk-taking, entrepreneurial approach to recovery can seem conservative and Conservative and at odds with the risk averse, managerial state bureaucracy where artificial targets, massaged figures and management speak replace experience, strength and hope.

At the moment we have a bureaucratic system measuring inputs and outputs such as access, retention and completion of treatment. In order to get a clearer picture of what drug treatment is actually achieving, we need to be measuring real world social outcomes such as jobs, homes and friends.

Take Successful Sid. Sid accessed methadone maintenance treatment as a heroin addict within days. He was retained there for years and left over six months ago. We can be sure that Sid won’t be returning to treatment because he is dead. People like Sid aren’t dying from acute opioid overdoses, they are dying from chronic physical health problems exacerbated by cheap alcohol – which he started drinking while in treatment.

It seems essential that we continue to look at which parts of the drug and alcohol treatment system work, and which parts are failing. The bulk of what happens in recovery actually happens outside of services – outside the formal treatment system.

Asset based community development (ABCD) has become something of a buzzword of late, but it is happening – often without any formal support or recognition. One strong example of a project based on ABCD principles is Jobs, Friends & Houses in Blackpool. It isn’t a treatment programme, but a business and a great example of a strengths rather than a deficits-based approach to the issues of drug and alcohol dependence.

At the UKRF conference in September, David Best argued that addiction/recovery are human rights issues, and the human rights deficit is most clearly shown by the exclusion of recovering people from the labour market. Programmes like Jobs, Friends & Houses provide an important model for how we can start correcting that deficit, but that’s just a single programme, in a single town.

Every year, thousands of people make the transition out of treatment into recovery in a very quiet, unsung way. Many want to reach out and offer the opportunities they have created for themselves to others seeking recovery who don’t want the formality of treatment or mutual aid within which to do it. Their politics is also probably more in line with the Conservative model of the Big Society, but rather than getting bogged down in labels and ideology, they just get on and do it anyway.

It’s always sad to see resources contracting in a field that you care about, but the truth is, drug treatment has been living high on the hog for much of the last 20 years. It’s going to be interesting to see the extent to which the reduction has an actual measurable impact on outcomes.

For the future though, we in the field need to start building on and making best use of those unpaid, unsung heroes who are delivering recovery both inside and outside the formal treatment system.

Mark Gilman is managing director of Discovering Health, www.discoveringhealth.co.uk; Peter McDermott is a policy professional and service user activist and Peter Sheath is senior associate with Emerging Horizons

Specialist recovery housing

No place like home

Phoenix Future’s new report Building recovery friendly communities makes the case for speciKaren Biggsalist recovery housing as a pathway to long-term recovery. Karen Biggs tells DDN why this is an opportunity not to be missed

From its unique position as both a drug and alcohol treatment charity and a housing association, Phoenix Futures has seen how pressures on the housing rental market are affecting people with drug and alcohol problems.

‘Changes in the housing world are increasing potential for people with substance misuse issues to have reduced housing options, either in treatment or when they exit treatment,’ says Phoenix Futures’ chief executive Karen Biggs.

At the same time, she points out, there are opportunities to bring together the housing and health agendas – ‘and if substance misuse isn’t in there when those conversations are happening, if we miss this opportunity, our service users will be seriously impacted… we will face the consequences further down the line.’

The charity’s new report (DDN, November 2015, page 4) sets out a housing pathway, starting with residential rehabilitation and moving through bridge housing – which prepares people to leave formal treatment – then into supported housing where they develop life skills, and on to recovery houses, and finally independent living.

‘This is what we think a housing pathway could look like in a local area,’ says Biggs. ‘It doesn’t have to be provided by one provider – use it as a starter to look at what you have in your area and how it supports someone as they’re moving through their recovery journey. Think about whether you are giving yourself the best opportunity to create that recovery friendly community.’

Phoenix are working effectively with partners in different areas, with the aim of making the housing recovery journey easier and helping people with tough choices.

Phoenix Futures housing 2‘Leaving treatment, housing options often restrict people from moving at their own pace and still getting the support they need,’ says Biggs. Working with other housing associations in some areas is proving effective in providing housing – independent living is central to the strategy they are now actively developing, and this involves finding landlords who understand about the recovery journey.

An understanding landlord can make a real difference to someone’s chances, she adds, as ‘if there’s a lapse they can be open and honest about it, rather than having to hide it from one of the most important stakeholders in their recovery. If there’s something that can be done to support them in independent living, that could be a conversation they could have with their landlord.’

Biggs hopes the document will open up a conversation between treatment providers, commissioners and housing providers. Many commissioners are already keen, she says, while community services have also welcomed the idea. Many housing associations also understand the issues, but there is a challenge in making sure these ‘don’t get lost’ with larger housing associations. Seeing initiatives come together can culminate in projects like Grace House, Phoenix’s new service in London for women with complex needs – the result of many conversations around how hard it is to achieve good quality, safe, stable housing for this group (and their families) and how hard it is for them to sustain treatment gains.

Keeping the service user at the centre of the model gave it clear direction from the start. ‘We came at it from a service user’s perspective,’ says Biggs. ‘We’d get them to think “what can I achieve before I leave?” and it’s about keeping that ambition. Peer support also played an important role: ‘It’s scary moving on to the next stage, so it’s helpful to see other people who’ve done it,’ she says.

Phoenix Futures housing 1Establishing a timescale for the recovery housing pathway involves a balancing act between being specific for the commissioner and being flexible enough not to impose too many constraints on the service user, particularly as ‘things get harder’ for them in the current climate.

‘Many of our service users have settled for “not good enough” when it comes to housing,’ she adds. ‘What we want to make easier is access to good, safe, secure housing and provide a full pathway. If we put the same effort into housing as everything else, it would be the best option for maintaining treatment gains.’

Building recovery friendly communities at www.phoenixfutures.org.uk

UK drug policy reform

Ian SherwoodOff track?

Drug treatment is being derailed by the sector’s refusal to push for reform, says Ian Sherwood

The distressing reality of drug dependence alters little over time, but society’s response to drugs and drug users has changed markedly over 30 years. During this time the field has developed an avoidance of the drug reform debate including decriminalisation, legal regulation and the role of criminal sanctions in treatment.

So why has this happened? The even-handed position we took then was usually a pragmatic one stemming from overriding priorities at the time; firstly to call for services for drug users in the 1980s, and then to argue the necessity and priority of harm reduction in the 1990s. Treatment providers were urgently distancing themselves from the moral panics stirred up in the tabloid press about drugs and HIV/AIDS, placing themselves within a safe, rational medico-therapeutic narrative.

For those on public platforms or official business representing treatment services it was a necessary but painful tactic to close down legalisation questions quickly, to ensure that the message about services wasn’t derailed by being ‘legalisers, soft on drug users’. Statements such as ‘my organisation is involved in treatment not politics’ became a default position.

It now appears that the parameters of acceptable debate have shifted to ‘recovery’ and little else. Despite a major upsurge in overdose deaths, talk of ‘harm reduction’ is increasingly taboo – and completely absent from government communications. The term ‘recovery’ has become a banner for anything broadly related to care, self help, therapy, coaching, training, social support, treatment and mutual aid. ‘Full recovery’ is the government’s preferred term, signalling a shift away from methadone towards abstinence-based interventions.

But the deployment of ‘recovery’ to mean everything to everyone leads again to the avoidance of debate and an inability to take positions. In 2015 this feels distinctly out of step with most informed opinion and global debate, disdainful of service user arguments for equality and social justice and ultimately negligent in reducing the risks and harms of drug use.

We all know that drug dependence only affects a very small minority of the many people who use drugs to the extent that they may require significant interventions. It is these clients of drug treatment services in the community and in prison that are cited by ministers as the justification for the Misuse of Drugs Act and the reason why legal regulation will not be entertained.

Treatment providers’ fear of biting the hand that feeds may have strong historical justification. But the factors that prohibition creates – a thriving black market with easy credit and violence – reduce the ability to provide treatment, undermine the communities in which drug use is most prevalent and demonise people who use drugs.

Now that’s what I call an obstacle to recovery and it’s time for the field to find its voice. It’s time to recognise that between those in recovery and those who provide treatment, care and support, there is a tremendous expertise that could articulate a way forward that is broad-based, constructive and reformist.

Disappointingly, it seems that the sector is content for almost anyone else to lead the way in this debate – even though it has potentially profound implications for them and their clients. Most recently police and crime commissioners have called for a ‘comprehensive review of strategy’ in a letter to the home secretary, with many chief constables also supporting reform.

When Portugal decided to decriminalise possession and replace it with a health response it wasn’t because they had discovered a radically effective approach to treatment; it was because they saw the criminal justice-led response as being both ineffective and harmful. In adopting a health-based policy they were choosing treatment approaches that have been used in the UK for more than 25 years – methadone, rehabilitation, detox, care planning, social reintegration – where people may still drop out of treatment, but can re-engage later without the threat of criminal sanctions.

Recent statistics on overdose in the UK are a depressing but timely corrective to the complacency regarding the success of drug treatment in the UK, and it seems very peculiar that no one is arguing for anything other than naloxone and training. It appears that an older cohort is dying, probably linked to the increased availability of imported heroin.

There hasn’t been any mention of drug consumption rooms (DCRs) – a widely researched, effective harm reduction intervention, again commonplace in Europe (and also found in Switzerland, Australia and Canada). Similarly, is anyone arguing for supervised injectable heroin – a well-researched intervention that comes under the heading of legal regulation? Surely if we are serious about wanting to stop people using and dying from illegal heroin we would look at quality evidence-based interventions for the hard to reach and the even harder to keep in treatment.

Another voice in the debate belongs to those who have been bereaved by drugs. The Families for Safer Drug Control group (now under the banner of Anyone’s Child, http://anyoneschild.org), are simply people who had lost a loved one to drugs and found the prohibitionist rhetoric hard to reconcile with their experience that in no way are drugs actually ‘controlled’ in the UK; all the laws seem to do is make drug use more risky and create vastly profitable, often violent, illegal marketplaces.

This, I would suggest, is the reality that most drug users, their families, service user organisations, the police and treatment providers see everyday – but the treatment providers aren’t talking about this, with some honourable exceptions.

Does your organisation take a position on drug reform? Take a look at the Count the Costs of the War on Drugs campaign (www.countthecosts.org), an in-depth and fully referenced resource on the reform debate, and sign up to examine the alternatives.

Ian Sherwood is a volunteer at Transform, www.tdpf.org.uk. He worked in drug treatment from the mid 1980s in voluntary and statutory sectors, as a clinician, manager and commissioner, and served three terms on the ACMD. He would love to hear from you at ian@tdpf.org.uk.

Benefits of therapeutic communities

RYinpragueAcademic notes

Drug sector veteran Rowdy Yates talks to David Gilliver about the value of therapeutic communities, and the therapeutic value of music

‘It’s kind of schizophrenic for me because one day I’m an esteemed academic doing my presentation and the following day I’m up on stage playing,’ says Rowdy Yates of last month’s annual conference at the San Patrignano community in Italy.

A passionate commitment to both therapeutic communities and music has defined his 46 years in the field, and although he resigns his post as senior research fellow at the University of Stirling at the end of this year, he’s staying on as president of the European Federation of Therapeutic Communities (EFTC) until 2017. And the community of San Patrignano (DDN, March 2014, page 8) is a shining example of what the sector can achieve, he believes.

‘It’s great,’ he says. ‘I mean, you’re talking about 1,500 people – it’s the biggest rehab in the world, really, and there’s a very strong, therapeutic community emphasis on self-help, self-governance.’

Is it a model that we could perhaps look at a little more closely in this country? ‘My view is that we could look at residential rehab much more closely and favourably than we do,’ he says. ‘We’ve had 20 years of thinking that residential treatment is profoundly expensive and therefore a last resort, and that means two things – one is that residential treatment has been marginalised, and the other is that it ends up treating the most chaotic, because you have to prove that you’re really, really messed up before you can get there.’

Much of the research comparing residential and non-residential models ‘doesn’t compare like with like’, he argues. ‘They’ll include the accommodation costs in the residential side of the equation, for example, but not in the non-residential side. I can understand why they do that, but the truth is that the majority of people receiving long-term methadone maintenance are probably also receiving housing benefit, so their accommodation is still costing the state. If you ignore that in an analysis then inevitably you make one side of the equation look more expensive.’ Studies rarely take account of the time window either, he states, with opioid-replacement therapy appearing affordable over the period of a year, but less so over ten.

One early ‘fundamental error’ of the harm reduction community was its failure to recognise, or effectively promote, the fact that it’s ‘actually about two things’, he says – reducing the harm that people do to themselves, and reducing the harm to other people.

‘The first is an entirely laudable aim, and one that’s entirely appropriate for drug treatment services. When I was running the Lifeline Project we were quite involved in needle exchanges and very clear that one of the major purposes was not just to reduce infection control, but also to look at how people were injecting and give them better advice. We kind of assume that long-term users know how to inject, but we forget that they were probably given inadequate advice when they started injecting, by people who’d also been given inadequate advice. We found long-term injectors who had appalling practices, which we were able to correct.’

Reducing harm to others, however, is something he’s ‘less convinced’ that treatment services ought to be involved in. ‘We can’t deny our responsibility to the community, but I know of a number of services who have workers going around giving clean needles and syringes to weightlifters who use anabolic steroids. Now there’s no indication that these people are addicted to those substances – so this is not addiction treatment, it’s not about resolving their drug problem, it’s about infection control.’

It’s possible that many people would be happy for treatment services to move away from a focus on addiction towards public health, infection control and crime reduction, he says, ‘but I’m not aware that we’ve ever had that debate. So that would be my reservation.’

An unintended consequence of harm reduction was to ‘effectively change the face’ of drug treatment, he believes. ‘Up until that point we were the good guys, taking people who were using drugs and making them better. After that, our priorities reversed. People who didn’t want to get better became our priority, and what we did with them in many cases, I suspect, was prolong their addictive experience. I continually meet people in therapeutic communities who tell me they were prescribed methadone for 15, 16 or 20 years. They feel angry about that and argue – with some validity, I think – that that prescription practice actually extended their addiction career.’

It’s a situation that in some ways reflects his entry into the field in the late 1960s, he says, which came via his own heroin use and a belief that if people wanted effective support they’d need to create it themselves. ‘A group of us ex-heroin addicts had been attending Alcoholics Anonymous, which at that time was about the only game in town. Drug dependency units, as they were known, were prescribing heroin and clearly didn’t believe in recovery, and really the whole of mainstream treatment in the UK and the states didn’t believe in recovery. So we decided we’d set up our own little support group.’

The spark was one member of the group coming across Lewis Yablonsky’s book, Synanon: the Tunnel Back, an account of a group of heroin users living together in a Santa Monica house – the Synanon community, later the subject of much controversy – but ‘not using’, Yates points out. ‘New York City probation department sent a group of experts out including Yablonsky, who was a sociologist, and he was so impressed that he didn’t come back. He stayed for a year and wrote the book. We read it and thought, “We could do this”.’ A priest provided an empty rectory building for very little rent and the group ‘just moved in, started doing it up and running our own therapeutic community – based on little more than Yablonsky’s description of how it worked’.

It was this community that ultimately led to the establishment of the Lifeline Project in the early 1970s, of which Yates later became director – ‘an addict who got lucky’, as he’s described himself, putting much of that good fortune down to the support of influential peers and mentors. ‘I’ve been very, very lucky in that respect’ he says.

Does he feel that the value of therapeutic communities has been properly recognised, or is there still a way to go? ‘No, there’s a very long way to go, and unfortunately I think the track we set out on was the wrong one, and we’re still reeling from the damage that caused. In my view, one of the major mistakes therapeutic communities made was to accept that they were about drug treatment. That effectively made them part of the health service, measured by those kind of randomised control trials that are very, very difficult to implement in such a complex intervention. There’s an argument that we took the shilling and became special hospitals, when really we should have become special schools.’

What such communities are really about is people learning to live and behave in a different way, he believes, and helping each other to do that in a structured environment. ‘That’s not really about drugs, and I’d like to see a big extension of therapeutic communities to many other areas – areas where, coincidentally, they’ve already begun to work,’ he says, pointing to those now seeing significant numbers of young women who self-harm as well as survivors of abuse or trafficking. ‘Those are areas that are entirely appropriate for that community-as-method approach. In some respects we’ve hamstrung ourselves into being simply about drug treatment, and I don’t think the approach is simply about that. I think it’s much broader.’

Is it too late to reverse that now? ‘I think so,’ he says. ‘One of the problems therapeutic communities and other residential agencies have faced over the last 20 or 30 years is the hijacking of some of the radical psychiatry notions about closing down big psychiatric institutions and moving people into the community. Right-wing governments – like Margaret Thatcher’s – hijacked that notion because they saw an opportunity to save huge amounts on health costs, not because they thought people could be cured in the community but because they thought, “We can close down this massive loony bin and sell it to Tesco”.’

That bred a notion of ‘residential bad, community good’ that still exists, he argues. ‘But I think we’re beginning to move out of that and recognise that it’s not really about residential and non-residential, it’s about treatment dosage. Some people will need a higher level of treatment intensity, a bigger dose, and the most effective way of delivering that is probably in a residential setting.’

The last decade or so has seen more and more people ‘fed up with being prescribed medicine for a social condition’, he says, or ‘seeing that happen to their relatives. It reached critical mass and they said, “We want something better”, something that mirrored the period in the late 1960s and early ‘70s when therapeutic communities originally appeared. You had a group of drug users, supported by radical psychiatrists, saying, “We can do better than this” and mainstream treatment saying, “No you can’t – the best we can do is control the whirlwind”. This belief in recovery is cyclical, I think, and we’re in one of those waves now.’

As the field continues to evolve and change, how does he feel about his imminent retirement from it? ‘I think it’s time, really, although I’m going to retain some of my responsibilities. Looking back, the major milestone for me was being made Phoenix Futures’ first – and only – honorary graduate. That was far more important to me than my MBE or other appointments over the years.’

His retirement will also give him the time to indulge his other passion, music, and his band Running wi’ Scissors plans to record an album to help raise money for therapeutic communities early next year.

‘I love playing music, but I kind of came out of it for a number of years and didn’t play at all, because for me my involvement in it was associated with my involvement in drugs. That’s where I started, when I was playing in bands in the ‘60s, so I kind of saw the two things together. I was frightened to play music, I suppose.’

The value of music and other creative activities in people’s recovery is something else that remains hugely under-appreciated, he says. ‘Music and drama and dance are often seen simply as ways of filling residents’ time – something they can do in the evenings. I think it’s much more important than that. We know from studies that playing music fires off synapses in the brain that don’t otherwise fire, so it has a profound effect on people’s thinking and self-esteem. That’s a really interesting area to explore.’

November DDN 2015

DDNnov15

In this month’s issue of DDN…

‘Talk of “harm reduction” is increasingly taboo – and completely absent from government communications.’

In the latest issue of DDN, Ian Sherwood asks whether drug treatment is being derailed by the sector’s refusal to push for reform.

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page. 

PDF Version / Virtual Magazine

Families First evening event

[contact-form-7 id=”12521″ title=”Families first evening event”]

Minimum pricing ‘could breach EU law’

The Scottish Government’s plans to introduce minimum unit pricing for alcohol could potentially breach EU free trade laws, according to an initial ruling by European Court of Justice advocate general Yves Bot. While the move would not be precluded by EU legislation, it would be legal only if it could be proven that it was the most effective public health measure available, he stated. The decision has been seen as a significant setback to the government’s plans.

In the case of The Scotch Whisky Association and others versus the advocate general for Scotland, Mr Bot ruled that ‘in order to pursue the objective of combating alcohol abuse, which forms part of the objective of protecting public health, a member state can choose rules imposing a minimum retail price of alcoholic beverages – which restricts trade within the European Union and distorts competition – rather than increased taxation of those products, only on condition that it shows that the measure chosen presents additional advantages or fewer disadvantages by comparison with the alternative measure.’

Increasing taxation would be ‘capable of procuring additional advantages by contributing to the general objective of combating alcohol abuse’, he stated.

Scottish first minister Nicola Sturgeon, however, has stressed that the legal process is still ongoing and that a final response from the European Court of Justice is needed before the case can return to the Scottish courts. ‘This initial opinion indicates that it will be for the domestic courts to take a final decision,’ she said.

‘While we must await the final outcome of this legal process, the Scottish Government remains certain that minimum unit pricing is the right measure for Scotland to reduce the harm that cheap, high-strength alcohol causes our communities,’ she continued. ‘In recent weeks statistics have shown that alcohol related deaths are rising again and that consumption may be rising again after a period of decline. We believe minimum unit pricing would save hundreds of lives in coming years and we will continue to vigorously make the case for this policy.’

Opinion of advocate general at http://curia.europa.eu

Comment from the substance misuse sector

Letters and comment

LettersDDN welcomes your Letters Please email the editor, claire@cjwellings.com, or post them to DDN, CJ Wellings Ltd, 57 High Street, Ashford, Kent TN24 8SG. Letters may be edited for space or clarity.

 

Marteau complex

We were shocked to see the title of a key article on the cover of last month’s DDN, Kill or cure: the dangers of diverted methadone. DDN’s approach was more in keeping with a tawdry tabloid splash rather than its usually more balanced magazine. Dave Marteau’s article asks: is it time ‘to reappraise our relationship with the life-saving drug methadone?’ He says he will discuss the evidence and this is what we want to challenge.

He starts with how methadone reduces deaths by 50 per cent, reduces HIV infection and how it has been positively evaluated by NICE. Then it seems as if Marteau does not know that methadone and buprenorphine are very different drugs. It is no revelation that methadone is potentially more dangerous than buprenorphine. Thus they are in different legal classes and schedules – unusually a sensible use of the classification system. But simply saying methadone is more dangerous than buprenorphine is like saying insulin is more dangerous than oral hyperglycaemic drugs and therefore we shouldn’t prescribe insulin.

He references the Auriacombe review of drug-related deaths in France between 1994 and 1998, which found buprenorphine was safer. This was when buprenorphine was first licensed and was first used in primary care and prescribed to people with less complex issues. This is a very important point. Many of us writing here are clinicians and have between us many, many years of experience. We will have cared for thousands of patients with drug problems and as a broad generalisation, the more complex, vulnerable, more likely to overdose and sick patients were settled much better on methadone and few of this group did well on buprenorphine. Keeping these patients in treatment is the most important thing – especially at the start. So using the medicine that does this most successfully is the obvious and right thing to do.

In his own study on which this article is based, The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales Marteau D, Macdonald R, Patel K. BMJ Open 2015; 5:e007629, they used fairly simple drug-related mortality data from two sources but posed some complex questions. We feel there is not nearly enough data to make any recommendation on ‘safe or unsafe’ prescriptions from this paper. Marteau needs to recognise that the nature of methadone – or buprenorphine – related deaths is a very broad church and association does not necessarily imply causation in all cases.

It is also an area where reporting bias may feature. In the Bell study there were 60 sudden deaths positive for methadone (32 in treatment) and seven buprenorphine-positive decedents (none in treatment). Most out-of-treatment deaths occurred in people with known histories of drug misuse, so is this a failure by drug services to engage with people? Might the diverted methadone actually be keeping many people alive who aren’t able to access treatment or couldn’t manage daily supervision? Also, isn’t it possible that those who were in treatment were inadequately dosed and self-treating with street methadone? It’s notable that the average dose of methadone across the six years of the Marteau paper was 46.6mg per day, way below the accepted therapeutic dose – what part did this play?

Using a single study, which like any academic paper has weaknesses as well as strengths, to suggest blanket recommendations on policy is indefensible. It’s a sensationalist, self-aggrandising approach that does an enormous disservice to public health. Methadone has many complex issues but it is a medication that has saved many lives in this country and around the world and continues to do so. Of course the issue of diversion is important and should be dealt with, but this article is at the very least unhelpful, and at the worst dangerous, particularly in this climate of rising poverty, social exclusion and drug-related deaths.

We implore Marteau to think seriously about the limitations of his paper before recommending potentially dangerous and unjustified policy changes.

Dr Chris Ford, clinical director, IDHDP; Dr Euan Lawson, deputy editor, British Journal of General Practice; Dr Clare Gerada, GP and ex-chair RCGP; Dr Judith Yates, GP and chair IDHDP; Dr Roy Robertson, professor of addiction medicine, Edinburgh; Dr Garratt McGovern, specialist GP, Dublin; Niamh Eastwood, executive director, Release; Dr Icro Maremmani, president, World Federation for the Treatment of Opioid Dependence; Dr Alex Wodak, emeritus consultant, Alcohol and Drug Service, St Vincent’s Hospital, Australia; Dr Robert Newman, director, Baron Edmond de Rothschild Chemical Dependency Institute, US; Joycelyn Woods, executive director, National Alliance for Medication Assisted Recovery, US; Dr Jasna Čuk Rupnik, MD, Center for Prevention and Treatment of Addiction of Illicit Drugs, Slovenia; Professor Barbara Broers, vice-president of the Swiss Society of Addiction Medicine; Dr Herman Joseph, NAMA, US

 

Dave Marteau responds:

I am reassured that experts now all seem to agree that methadone is more dangerous than buprenorphine. The published evidence to date indicates that it is around five times more lethal. Again, all seem to agree that methadone diverted from the treatment system is the main source of these tragedies. A total of 2,366 of our fellow citizens dying with methadone in their systems in just six years is hundreds, if not thousands, too many.

I have already given my views on this very important subject, so I (and I imagine DDN) would welcome the thoughts of other readers.

 

DDN is a non-partisan forum for debate and all views are welcome.

Editor

 

Red alert

I work in an emergency accommo­da­tion facility, and I recently completed a two-day trainer course on naloxone. Now we have been told we cannot store naloxone on the premises – neither will they fund a kit for myself! Red tape gone mad… again!

Jim Kirkwood, Glasgow

Local news from the substance misuse field


Prison visitDuchess of cambridge visits treatment programme

The Duchess of Cambridge visited HMP Send this month to see a RAPt addiction service in action.
The programme, based in a standalone women-only unit, is an intensive 12-step drug and alcohol programme. The Duchess heard personal stories from some of the women about their experiences with addiction and crime, and how the programme was helping them to overcome their addiction.

‘I was reminded today how addictions lie at the heart of so many social issues and how substance misuse can play such a destructive role in vulnerable people’s lives,’ she said. ‘I saw again today that a failure to intervene early in life to tackle mental health problems and other challenges can have profound consequences for people throughout
their lives.’
Film festRecovery film festival draws to a close

The Recovery Street Film Festival ended its nationwide tour in Sheffield on 26 September, after showcasing short films made by people in recovery to audiences across the UK to raise awareness of drug and alcohol problems.
The pop-up cinema event – organised by Addaction, Action on Addiction, Blenheim, Northumberland Recovery Partnership, Phoenix Futures and Turning Point – toured across Durham, Blyth, Manchester, Glasgow, London and Sheffield over two weeks during recovery month.

The aim of the festival was to reduce stigma surrounding drug and alcohol problems by showing the public three-minute films of personal accounts of addiction and how people’s lives have changed. The top ten films entered into a competition run earlier this year were chosen by a panel of judges, with the top three entries winning £1,000 worth of prizes.

‘The Recovery Street Film Festival has been a huge success and we received a great response from members of the public and people in recovery who volunteered to help run the individual events,’ said Bob Campbell, Recovery Street Film Festival organiser. ‘We hope the festival has challenged the public’s views about people who have overcome addiction, and given hope to people who are currently being affected by problems with drugs and alcohol that there is possibility of a better future.’

 

Primary schools asked to think again about alcohol

Drug and alcohol charity Swanswell is asking primary schools to re-evaluate their relationship with alcohol at events such as school fetes and sports days.

Research by the charity suggests that around one in three primary schools in England are serving alcohol to adults at events aimed at children. Swanswell is calling for a change to licensing laws, so that any application from a primary school to serve alcohol at events aimed at children is refused. It is also asking schools to think again before gifting alcohol in raffles or allowing children to take in alcoholic end of year gifts for teachers.

 

Hope festivalTruro festival celebrates recovery

A ‘festival of hope’ was held this month at Boscawen Park in Truro to celebrate the recovery successes of people in Cornwall.
The day, organised by Addaction volunteers and staff, was opened by Truro’s mayor Cllr Lorrie Eathorne-Gibbons. To keep the crowds entertained, there was live music, good food and local stalls – as well as the opportunity to hear from people who shared their own stories of recovery and volunteering.

The event raised more than £1,000 for Addaction’s Cornwall recovery cafés. One volunteer, Mat Wilkin, raised £500 himself by having his head shaved on the day.

 

StoptoberService users offered support to quit smoking

Local people in recovery in Doncaster are being offered support to help them quit smoking.

Staff from Doncaster Drug and Alcohol Service (DDAS), run by Rotherham Doncaster and South Humber NHS Foundation Trust (RDaSH), have been trained to give stop smoking advice and are working with individuals to try to reduce their risk of premature death.

A number of service users have already quit since the start of 2015, and DDAS is encouraging those who use its services to take part in the ‘Stoptober ‘challenge. DDAS will be offering support, as well as nicotine replacement, across all its Doncaster premises.

Alcohol and drugs in the news

Media savvy

The news and views from the national media

Laws against smoking have irreversibly shifted attitudes. The same drive is needed for alcohol consumption. The police, magistrates and judges must insist on rehab for alcoholics as they do for drug addiction. And finally, while the NHS must care for those already addicted, it needs to get tougher on those who won’t stop drinking till they are blotto. Inform their employers or the benefits office. Show them there is no such thing as a free bed. Shifting a culture is not easy but it can be done.

Yasmin Alibhai-Brown, Independent on Sunday, 6 September

The [charity] sector is crying out for rationalisation through merger. It’s been talked about for years; but the holier-than-thou approach many charities take to their cause, combined with their ad hoc back offices, means that there’s little motivation to develop in this way… We need a Big Bang in the sector, with potential and existing charities required to justify why they are not joining others sharing the same purpose.

Matthew Patten, Telegraph, 3 September

People refer to our culture as ‘alcogenic’. It isn’t, it is alcophiliac. Drink is not merely the socially acceptable addiction, but the socially approved fix. Alcohol is how our society detaches itself from stress, be it the angst of work or parenthood. It is how it celebrates and mourns, marks the holiday and the everyday. Millions of people – like me – come under the category ‘functional alcoholic’, as if the ‘functional’ somehow negates the disease.

Hannah Betts, Telegraph, 14 September

The debate on minimum pricing for alcohol will now switch from the courts to the academic arena and the researchers will be asked to provide the proof of the policy the government wants to implement. When a government looks to academia to provide evidence for its favoured policy we should all be uncomfortable. Universities love government funding – they depend upon it. So the temptation will be to accept the government’s largesse and to deliver the findings the government wants to hear. Only in this case, the audience will not be sympathetic Scottish Government ministers, but sceptical European legal experts.

Neil McKeganey, Scotsman, 7 September

A mother who paid £300 for a dozen packets of cocaine as a birthday present for her daughter’s 18th has been spared jail. Nicola Austen, 37, with six previous drugs convictions, expected to be sent to prison and turned up at Maidstone Crown Court with an overnight bag. But the judge gave her a suspended sentence and community service because she is a ‘carer’ for her 14-year-old son and her elderly grandmother. Run that by me again. A woman who buys cocaine for her teenage daughter is spared jail because she is considered a suitable person to look after a 14-year-old boy? Am I missing something here?

Richard Littlejohn, Mail, 11 September

Drug poisoning deaths hit highest level ever

Last year saw England and Wales register the highest number of drug poisoning deaths since records began more than two decades ago, according to figures from the Office for National Statistics (ONS).

There were 3,346 drug-poisoning deaths registered in 2014, almost 70 per cent of which involved illegal drugs. The figures came just over a week after Scotland also recorded its highest ever number of drug-related deaths for the same period (DDN, September, page 4).

Deaths involving heroin and morphine increased sharply between 2012 and 2014 – from 579 to 952 – while deaths involving cocaine also jumped dramatically, from 169 to 247 in the space of a year. Cocaine-related deaths have now increased for three years in a row, reaching an all-time high of 4.4 per million population. However, while England saw a 17 per cent increase in its drug misuse mortality rate – to 39.7 per million population – Wales saw its proportion drop by 16 per cent to 39.0 per million, the lowest figure for almost a decade.

In England, the north east had the highest mortality rate and London the lowest. As was the case in Scotland, most deaths occurred among older people, with the highest mortality rate in the 40-49 age group, followed by those aged 30-39.

Treatment charity Addaction said the stark figures meant the government now needed to rethink its proposed cuts in local authority health spending (DDN, September, page 4). ‘Drug treatment services across the country have seen an increase in the number of people seeking help for opiates and/or crack cocaine, and this is only likely to increase further as the effect of increased opiate availability and purity is felt,’ said chief executive Simon Antrobus. ‘Meanwhile, the Department of Health are proposing a £200m reduction to the public health grant, which will hit the capacity of drug services commissioned by local authorities.’

The government needed to ensure local authority health spending was given the same amount of protection as that promised to NHS-commissioned services, he stated. ‘The stakes are simply too high to do otherwise.’

Deaths related to drug poisoning in England and Wales, 2014 registrations at www.ons.gov.uk

Post-its from practice

Steve BrinksmanSometimes the drug or alcohol problem isn’t obvious, says Dr Steve Brinksman 

Marco rarely came to the surgery. He was a 44-year-old restaurant owner with two young children but on a routine screen had been picked up as having high blood pressure. He had been given advice to lose a little weight and exercise more, but this made no significant difference. He was started on an anti-hypertensive and his blood pressure improved; but 12 months later it was up again, and as he was adamant he was taking his medication every day, a second drug was added in.

Three months later one of our registrars noticed his blood pressure was again poorly controlled. Rather than add in a third drug she decided to discuss this with me as part of her learning portfolio.

We went through his notes. He had been overweight but his body mass index (BMI) was now 26, so this was unlikely to be a significant factor. He had stopped smoking when his first child was born seven years earlier, his renal function was normal and no significant past medical history was recorded. I asked her if he drank alcohol. ‘I’m not sure,’ she said and indeed nothing was recorded in his notes about alcohol consumption. I explained that excessive alcohol use was a major factor for hypertension and cardiovascular disease.

He was due for review the following week and after this we caught up. He had told her he drank a bottle of red wine every day, as it was good for his heart! She had explained to him about the effect alcohol has on high blood pressure and cardiovascular disease and he had been shocked by this. He decided to try and cut his alcohol down rather than take a third medication. His blood pressure improved over the next few weeks and it was possible to stop one of his tablets.

I was the next person to see him and this time his blood pressure was within the normal limits while he was still taking a single drug to control it. He told me he had reduced his alcohol to half a bottle one night during the week and half a bottle each day over the weekend.

I wonder how many patients have physical and mental health problems related to their drug or alcohol use that pass unnoticed because a health professional doesn’t ask. We are trained to ask difficult and/or embarrassing questions, yet so often we don’t.

As part of our commitment to improving the treatment of alcohol users, SMMGP have launched an online training module about the community management of alcohol use disorders which can be completed free of charge at www.smmgp-elearning.org.uk

Steve Brinksman is a GP in Birmingham and clinical lead of SMMGP, www.smmgp.org.uk. He is also the RCGP regional lead in substance misuse for the West Midlands.

National news from the substance misuse field

A round-up of national news – October 2015

Emergency inquiry

An inquiry into the impact of alcohol-related incidents on the emergency services has been launched by the All Party Parliamentary Group on Alcohol Harm. Alcohol-related harm costs the NHS an estimated £3bn per year and puts intense pressure on services, particularly at weekends. A central objective of the inquiry will be to ‘build a clear picture’ of the time and resources lost to alcohol, said group chair Fiona Bruce MP.

 

An involving document

A new guide detailing the benefits of involving recovering drug and alcohol users in treatment design has been published by PHE. The guide sets out the different levels of user involvement, with useful examples of good practice. ‘Those who have recovered from addiction themselves have the experiences, and often the expertise, to help others and can make an important contribution to the development of successful services,’ said PHE’s director of alcohol, drugs and tobacco Rosanna O’Connor. Service user involvement: a guide for drug and alcohol commissioners, providers and service users at www.gov.uk

 

Götz goes

Alexis Goosdeel has been appointed as the new EMCDDA director, the agency has announced. He takes up the position next January, replacing Wolfgang Götz, who has held the post since 2005. Mr Goosdeel has been at the EMCDDA since 1999, before which he co-founded Belgian harm reduction NGO Modus Vivendi.

 

BBV boost

A new briefing to support local authorities and drug services in reviewing their BBV prevention and treatment interventions has been published by PHE. Preventing blood-borne virus transmission among people who inject drugs draws together published evidence and guidance, as well as feedback from treatment services. Available at www.nta.nhs.uk/r-Evidence%20and%20Guidance3.aspx

 

Boundary change

‘Locally-led and coordinated’ action is vital to support people with multiple and complex needs, according to a new report from the Institute for Public Policy Research (IPPR). Public spending on individuals experiencing problems like addiction, homelessness and offending is still ‘largely reactive’, says the document – preventative support would deliver better results and save money by avoiding duplication and avoiding the need for expensive crisis care. Breaking boundaries: towards a ‘troubled lives’ programme for people facing multiple and complex needs at www.ippr.org

 

Penalty points

A new tool to instantly compare the penalties for drug possession and supply across Europe has been developed by EMCDDA. Searches can also be refined according to drug type, quantity and the ‘addiction or recidivism of the offender’. Penalties for drug law offences in Europe at a glance at www.emcdda.europa.eu

Substance misuse safeguarding

Kevin CrowleyOn the safe side

We mustn’t be afraid to engage with parents about sensitive safeguarding issues, says Kevin Crowley

As a social care and health charity, CRI works with individuals, families and communities across England and Wales affected by drugs, alcohol, crime, homelessness, domestic abuse, and antisocial behaviour.

Working with this at-risk group of people, it is imperative that certain safeguards are observed. Service users who seek our help are often in an extremely vulnerable position and may need support with not only the physical effects of substance abuse, but with the effects it can have on their lifestyle, family and professional lives. Our priority is to always help service users create a safe environment, which will ultimately help their recovery process.

Safeguarding particularly applies when the service user is caring for children. As an organisation, CRI has a shared responsibility to ensure that the children of parents struggling with alcohol or substance misuse are safe and protected. While we can never completely eliminate risk, we put our energy and resources into reducing it as much as possible.

A key concern for these often vulnerable children is to limit, as much as possible, exposure to substances. At CRI, we treat heroin-dependent service users with opiate replacement medications which are by their nature potentially dangerous drugs. Any service user who is given methadone, for example, will be provided with a safety-locked box that will prevent children from directly accessing it. Staff conduct home visits, starting from as close to the initial distribution as possible. A vital aspect of these home visits is to ask questions and not make assumptions, as well as educating parents on the risks posed to children around medication. Frontline staff are trained to use their expertise and professional initiative to assess the home environment of a child.

We work with multiple organisations across the social care sector, including local auth­or­ities, police, and social services, to provide a well-rounded and holistic care system. Collaboration and communication is key to giving parents the best possible support, ensuring that separating a child from its parents will only ever come as a last resort. As a drug and alcohol rehabilitation charity, we support parents with substance issues but will always work with or refer cases to other organisations, should their expertise be better placed.

Our safeguarding approach at CRI is to do everything we can to minimise risk. In an ideal world we would reduce risk to zero, but as we are often tragically reminded, in the real world of recovery this is not possible. A fundamental principle is working with our service users and other professionals openly and collaboratively, and not being afraid to engage with them on risk and safeguarding issues. Welfare of their children is not only paramount for us but for the vast majority of parents in recovery.

Kevin Crowley is executive director of quality, governance and innovation at CRI

Experts on safeguarding will be speaking at a national conference in Birmingham on 10 November, presented by Adfam. Details and booking at www.drinkanddrugsnews.com/safeguarding-conference

 

 

Recovery month 2015

Recovery round-up

Throughout September, thousands of people across the UK got together to celebrate recovery – with fund-raisers, festivals and plenty of fun. DDN gets a glimpse of some of the action.

Getting stronger

With more recovery events taking place than ever before, UKRF founder Alistair Sinclair looks at why UK recovery month is going from strength to strength

On 1 September 2013, around 100 folk climbed Snowdon to mark the beginning of the first UK recovery month. While recovery month has been celebrated in the US for many years, and the UK recovery walks started with a memorial walk in Liverpool in 2009, 2013 was the first year we saw a range of recovery activities all over the UK in September. There were 49 events in 2013, and 2014 saw 102. This year, we’re aware of 166.

Recovery month 2015 kicked off in Manchester at the seventh national UKRF event, where around 250 UK activists gathered to explore the role of recoverists in an ‘age of dislocation’. Thousands of people made recovery visible at recovery walks, around 26 of them across the UK – including walks in Dublin, Glasgow and Durham.

Other communities held family fun days, music festivals, dance events, film nights, harm reduction cafés, plays, sports events, workshops and unity days. One recoverist, Lexi West, set off to climb to Everest Base Camp to raise funds for recovery communities and plant flags for the fallen.

The variety of events in recovery month and the passion behind them was incredible and inspiring. It was a month dedicated to community building and hope. The UKRF believes we all need a month like this – highlighting our similarities as human beings, the core values that connect us and the belief that we can, all of us, recover.

www.ukrf.org.uk

Recovery festival

Walk this way

The UK recovery walk has just completed its seventh year on the trot. Its founder Annemarie Ward talks about how it’s kept up momentum

This year, the annual UK recovery walk was held in Durham, writing another chapter in the history of addiction recovery in the UK. At the recovery, spirituality and families conference in Durham Cathedral the day before the walk, and during the walk itself on Saturday 12 September, we went some way in challenging the social stigma attached to addiction. The UK recovery movement has matured further this year. As in our personal recovery, masks of arrogance and intolerance give way to greater humility and acceptance, and as a movement overall we have celebrated greater unity in strength and experienced greater strength in unity.

There have been many people who have worked tirelessly to make sure recovery month events went off without a hitch. It’s fantastic to see it go from strength to strength. With the conference and the walk in Durham this year, many of the people of the north east got to know, see and feel what recovery is.

As a charity, we are grateful for that, and even more so for how the people of the north east worked with, cared for and loved us. Our sincerest gratitude goes to every single person who played a role in international recovery month.

Going for gold

Neil Firbank of New Beginnings recaps the activities of this year’s recovery games

Wow, did this year’s games really exceed our expectations! We knew, based on the last one, that it would be popular, but I never expected that 25 teams would turn up on the day. That meant in total around 400 competitors took part, battling against each other in a wide variety of events.

The games drew around 300 spectators, from family members and the local community, who were all amazed at the message we were spreading, and hopefully went some way to reducing the stigma faced by those taking part.

The original idea for the games came from watching how the Olympics 2012 really pulled everyone together and ignited a community spirit. I wanted to organise an event that somehow captured that, and showed people that we do get better – that you would never believe that the person next to you could ever have had issues with substances. It also had to be fun.

Eventually, the games drew to a close with five teams facing each other in a grand finale of didicar time trial racing. Active Recovery from Scunthorpe came away the overall winners, and took away the coveted recovery games shield.

The games turned out to be a fantastic day, and we managed to raise over £500 for Aurora, a local cancer respite charity. Watch this space for next year’s recovery games – it can only get bigger and better.

www.drughub.co.uk

Recovery festival 2

Moving forward

Forward Leeds staff, volunteers and service users also attended the UK recovery walk to meet and connect with the local recovery community. The walk led crowds through the city centre, past Durham Cathedral, and provided live music, stalls and activities – as well as a performance by the UK recovery choir and rap artist Ben SoS Riley.

The Le Tour de Recovery also joined the walk, after cycling to Durham from Leamington Spa. The ride raised money for UK FAVOR, as well as awareness for the importance of communities sustaining recovery.

Festival feeling

Jack Hall of Bristol Drugs Project shares what went down at the third recovery festival

This year’s festival captured its biggest audiences ever, with attendees from recovery communities across the south west.

Established in 2013, the recovery festival is a free annual event that celebrates recovery from addiction by bringing people together to share their strengths, hopes, achievements and, most importantly, their talents.

This year’s festival featured an array of local musicians, as well as fantastic performances by Bristol’s recovery choir Rising Voices and the Bristol Drugs Project theatre group. Topping the line-up were guest speakers Annemarie Ward, founder of the UK recovery walk, and Tony Mercer of Public Health England.

The day featured a selection of great food and refreshments, as well as alternative therapies, taster support groups, and the opportunity to browse the stalls of local communities and services to find out what opportunities are available to people thinking about treatment, or in recovery.

www.therecoveryfestival.co.uk

Recovery festival 3

Harm reduction at the NNEF meeting

On the front line

MMatt Johnstoneatt Johnstone brings harm reduction news from the annual NNEF meeting 

The National Needle Exchange Forum (NNEF) held its annual meeting in Birmingham last month. The meeting brings together members of the NNEF to present the latest news and updates on harm reduction for needle exchange workers, harm reduction advocates and service users, with a number of exhibitors including Frontier and Exchange Supplies displaying the latest products for needle exchange programmes.

There were presentations on the latest developments on naloxone and updates from Public Health England (PHE), as well as updates on the work of the NNEF over the past year. Alongside some of the presentations there were overdose and naloxone training sessions, delivered by NNEF deputy chair Philippe Bonnet and Kevin Jaffray.

Naloxone changes ‘just a start’

The morning sessions focused on updates and changes to legislation regarding the provision of naloxone. Kirstie Douse from Release presented the legal implications of the changes, highlighting that the new regulations are a good start but don’t go far enough as there is still no national programme or requirement to provide naloxone, resulting in a postcode lottery.

Nigel Brunsdon spoke about practical ways to embed naloxone provision into services, showing the importance of developing protocols and policies as well as working with local partners to raise awareness.

‘When it comes to starting naloxone within your service, it is so important not to let the development of paperwork be a barrier to getting started,’ he said. ‘However we do need to monitor the programmes to evidence the effectiveness to others, as well as working with commissioners at all levels to make naloxone provision a key performance indicator.’

NNEF 1Policy updates

Speakers from PHE and the Home Office provided the latest news from public health. Among them were Viv Hope who outlined the recent emergence of mephedrone injecting in the UK from the unlinked anonymous monitoring survey (UAM) among people who inject drugs. He highlighted that ‘there are higher levels of risk and infections among those who have injected mephedrone, with one in 12 among survey respondents having injected mephedrone within the last 28 days.’

‘Interventions needed’

Katelyn Cullen from PHE drew insights from the UAM survey into neck injectors, outlining that interventions are required to improve injecting technique and reduce misconceptions around this practice.

There were also updates from the Home Office with David Ryan-Mills looking for services to get involved with their plans to evaluate foil provision in England.

NNEF developments

Jamie Bridge, chair of the NNEF, gave an overview of the work completed by the NNEF within the past year, including the creation of a directory of all the needle exchanges in England following the Freedom of Information request to 152 directors of public health.

‘NICE guidance recommends that directors of public health ensure that services are commissioned to deliver a range of generic and targeted needle and syringe programmes to meet local needs,’ he said. ‘Without a central database or map of exchanges, it is difficult to assess the implementation and coverage of NSPs.’

As deputy chair of the NNEF, I launched the ‘secret shopper’ project to assess the service offered by NSPs within drug services and pharmacies. The main aims are to assess the availability of access to clean injecting equipment, and whether people accessing NSPs are treated with dignity and respect.NNEF 2

The NNEF is currently recruiting service users, service user groups and harm reduction advocates to become secret shoppers to find out what is happening in the real world.

The day finished with keynote speaker Sara McGrail, who gave an inspirational presentation on what the increase in drug-related deaths might be telling us about our drug treatment system. Highlighting the concerns for the sector with the de-prioritisation of harm reduction, changes in the culture of drug services in England as well as the impact of service commissioning and recommissioning every few years, she called for the ‘urgent and focused thematic CQC review of service and commissioning, including contracts in those areas which have the highest rises in opiate-related deaths.’

For more information about the presentations and to join the NNEF (membership is free) visit www.nnef.org.uk

Matt Johnstone is deputy chair of the NNEF

Pics by Nigel Brunsdon

Addictive behaviours conference

The appliance of science

The first pan-European multi-disciplinary conference on addictive behaviours looked at how science and research can translate into policy and practice. DDN reports

‘Addictions, above all, are a health problem – but they can’t be solved by health interventions alone,’ state secretary to the Portuguese Ministry of Health, Fernando Leal Da Costa, told delegates at the opening session of Lisbon Addictions 2015. Portugal’s groundbreaking policy of decriminalising personal drug possession was one that other countries could learn from, he said. ‘We acknowledge that it’s not perfect, but we do believe that it’s a sensible and rational approach.’

The policy had been fully monitored and the plan was now to further develop it in cooperation with other Portuguese-speaking countries, he said – ‘a way to expand our interventions’. However, Portugal was struggling with the reintegration of people who’d had drug problems, particularly in terms of employment opportunities in the current economic climate, and was aware that more needed to be done in terms of prevention. ‘Much more also needs to be done, Europe-wide, on the issue of alcohol,’ he stated. ‘We need to revisit the alcohol strategy in terms of the whole continent.’

Even defining addiction could present problems, said Robert West of University College London. ‘It’s a complicated subject, with a lot of different components. But we do know that it arises out of learning, which means there’s a huge overlap between neuroscience and behavioural science.’ The question was how to get the best return on investment – not necessarily in monetary terms, but in terms of benefit to society, he said.

Conference 1There was a tendency for people in the field to compartmentalise their favourite model of addiction, he pointed out, whether that related to ‘reward, self-medication, relief from withdrawal, habit, acquired drive’ or other models. ‘All of them have some validity, and in terms of interventions we can educate, persuade, coerce, incentivise, enable, restrict and more. They’re broad-brush things, but all will be relevant at some point.’

For any behaviour to occur, three things had to be in place, he said – capability, motivation and opportunity. ‘So if we do ever manage to crack the problem of addiction, that would be quite a scary thought – it means someone will have a very powerful behaviour-change tool at their disposal.’ Policies and interventions could be informed by neuroscience, he said, and it was now time for a ‘major review of the research strategy underpinning the approaches we take to combatting addiction. I don’t mean a bunfight about where the money goes – just an analysis of how we do it.’

‘There are many levels of ongoing research that are essential to understanding addiction and effective interventions,’ added neuroscientist Marina Picciotto of Yale University. ‘But we do need research that determines the efficacy of the interventions out there.’ One example was Alcoholics Anonymous, she told delegates. ‘Are there options that aren’t being used because there’s this dominant paradigm?’

Neuroscience research had permeated the study of addiction, and public policy, to the extent that it was now ‘practically invisible’ she said, and had been highly successful in developing new interventions. ‘It can identify the primary molecular targets for drugs of abuse, as well as defining circuits, neurotransmitter systems and the really long-term changes that can explain cue and use and so on. It’s even defined the exact molecules in the brain that nicotine binds to.’

However it was important to remember that neurobiology and holistic approaches were not mutually exclusive, she stressed. ‘We do need hybrid neurobiological and behavioural interventions based on what we know about neural systems, and we need to get beyond the “one pill will fix it” philosophy.’

‘The world is a very complicated place,’ agreed Robert West. ‘It’s about finding the right angles to approach things from.’

On the issue of whether treatment was even the correct first response to addiction problems, Mark Kleiman of UCLA’s Luskin School of Public Affairs told the conference that ‘most people who use habit-forming substances do not go on to form bad habits, with the exception of nicotine. With all other substances, rates from initiation to problem use are low. Addiction is not a characteristic property of the use of addictive materials, and I’d also say that most people recover spontaneously – that is, without formal interventions.’

However, spontaneous recovery was usually a reaction to outside events, he stressed – ‘getting a job, pressure from loved ones, things like that. Most people who seek help do so through voluntary self-help programmes such as AA, and the outcomes tend to be just as good as paid treatment. So if you’re a clinician the people you’re going to see are those who didn’t recover spontaneously. But spontaneous recovery is based on a range of external conditions, so we need to make sure the right external conditions are in place.’

This was very different from addiction being a chronic relapsing disorder, he argued, ‘so when we require treatment of someone who’s been arrested for drug possession, for example, we’re making a mistake that can start a cycle of unjustified and ineffective punishment. Involuntary treatment should not be a first resort, as it is in too many cases. If one definition of addiction is to continue to use in the face of adverse circumstances – for example, very intense enforced treatment – then your diagnosis is made. In the US a very large percentage of people with drug problems are under criminal supervision.’

However, the outcomes of treatment were ‘multi-dimensional’, he said. ‘One way to think about treatment is to think about the other problems that people have – treatment should be measured by overall outcomes, not just drug outcomes. The goal should be achieving the best available outcomes for people with substance problems, and the people around them, by whatever means.’

Conference 2‘Do we need treatment as a first response? Yes,’ countered Gabriele Fischer of the University of Vienna. ‘It reduces deaths, reduces use, reduces HIV and HCV risk and saves money. Some say, “why spend the money when people relapse?” Well, relapse isn’t limited to drug treatment – it also applies to the treatment of chronic conditions like diabetes, asthma, hypertension. And when people talk about dependence on methadone, remember that people are also dependent on drugs for diabetes, asthma, hypertension. What’s unique in our population is the percentage of people who are ending up in the criminal justice system.’

In terms of whether those polices would change, Mark Kleiman told the conference that, ‘I’m sure cannabis will be fully legalised in the US in ten years. But I’m only moderately happy about that. If you were going to pick a country to legalise cannabis in you wouldn’t choose one where the courts had ruled that any legal activity can be advertised and promoted without limits. I think we will lurch from prohibition – which admittedly doesn’t work – to the most extreme version of legalisation, and you only have to look to alcohol to see the model for what we’ll have.’

When it came to whether academics should even try to influence policy, views varied, said Linda Bauld of the University of Sterling. ‘It’s very context-specific, and we have to show that there’s a positive impact on society or the economy.’ A great deal had been written about the gaps between research and policy, she said, and addictions research often responded to policy ambiguity by ‘trying to improve the supply of evidence – but that tends to ignore the importance of other factors. It’s very often a long game.’

Alcohol policy was a case in point, she said, where research findings came up against the power of the drinks industry, government indifference, media hostility, low levels of public awareness and other factors. ‘So research alone isn’t enough, but being an advocate for the evidence certainly helps.’

Research into new psychoactive substances (NPS), however, had helped to both inform policy and practice and challenge myths, said Felix Carvalho of the University of Porto. ‘Those myths included that NPS are safer than street drugs, contain fewer contaminants and are associated with lower health risks – general addiction pathways are the same.’ However, researchers tended to publish their findings in scientific journals, he said. ‘And politicians don’t read those. So we do need the mass media.’

Things had changed dramatically for people with addiction issues in the US over the last few years, said former White House ‘drug czar’ Keith Humphreys, now at Stanford University’s School of Medicine (DDN, June 2012, page 16). The 2010 Affordable Care Act – or ‘ObamaCare’ – had defined mental health and substance use as an ‘essential healthcare benefit’, as well as allowing parents to keep their children on their private insurance plans until the age of 26 – and ‘almost all substance use problems have an onset early in life,’ he said. ‘So access to, and insurance coverage for, substance treatment has never been better in the US.’

This meant the law was driving the integration of previously ghettoised specialities into the mainstream, ‘where they belong’, he said. ‘But is science supposed to define policy by itself? Science is very good at identifying emerging problems, and it can also suggest new polices and determine whether existing policies are working. But it can’t tell us what we care about.’ Ultimately, politicians had to make value judgements, he said. ‘You can’t fund everything. Just because we’re experts in science doesn’t make us experts in government.’

The main routes through which findings eventually translated into policy were media coverage, professional and grass-roots organisations, scientists engaging the bureaucracy – both formally and informally – and scientists in policy-making roles themselves, he said.

‘US healthcare policy around substance use has changed dramatically. Scientists did not cause that to happen – they shouldn’t expect to, and no one should expect them to. But when you have political will combined with good research and evidence – that’s when you can really make a difference.’

Potent cannabinoid use

Adam Winstock

Reinventing cannabis

Why are ‘risky’ and ‘unpleasant’ new versions of cannabis replacing the real thing? Adam Winstock shares findings from the Global Drug Survey.

For the last decade much about harm reduction for cannabis was pretty straightforward. Nothing much had changed apart from the dominance of high potency herbal cannabis and its association with higher rates of paranoia, memory loss and dependence.

Then a few years ago things changed with the reappearance and remarketing of hash oil and the emergence from underground laboratories of myriad synthetic cannabinoid compounds. Both have been driven by the potential for huge financial gain, with hash oil riding on the back of the legitimisation – through medicine – of cannabis and the convenient appearance of vaping technologies, and synthetic cannabinoids exploiting a gap in the market for an unregulated cheap ‘stone’ in the face of very expensive herbal cannabis.

Butane hash oil (BHO, also known as shatter, honey and wax) is a new potent form of cannabis with THC of 60-80 per cent (and varying levels of CBD) that has seen a huge rise in popularity in the USA in recent years, driven by a demand among those with medical conditions for preparations that could minimise smoking-related harms and facilitate easier consumption. So just like the synthesis of opium to morphine, the movement to create a stronger and more potent form of cannabis might have therapeutic value.

These concentrations might also carry harm reduction benefits (eg smoking less combustible product, promotion of oral use, less consumption of unwanted impurities), which could extend to the non-medical use community. The development of a more potent form of drug is often partnered with a more efficient route of delivery. In the case of BHO the rapid evolution in ‘vape’ technology has been the perfect accompaniment.

Global Drug Survey (GDS) has been researching the use of natural cannabis preparations and the emerging issues associated with synthetic cannabis products for the last five years. Since 2012 we have collected data from over 150,000 cannabis users and have used this huge pool of expert knowledge to produce a range of free, peer-led harm reduction and self-assessment tools. These include the cannabis drugs meter www.drugsmeter.com, where you can compare your use with 100,000 others; the highway code, www.globaldrugsurvey.com/brand/the-highway-code (the first guide to talk about the impact of various harm reduction strategies on risk and drug-related pleasure), and the world’s first safe-use guidelines for cannabis at www.saferuselimits.com. All of these tools support our aim of making drug use safer, regardless of its legal status.

More than 2,500 users of BHO took part in GDS2015 and we found that BHO did indeed allow the use of non-tobacco routes of administration. Overall, most effects of BHO were reported to be stronger, last longer, and take effect more quickly than high potency herbal preparations. In terms of risks of dependence and withdrawal, most users reported little difference. As ever, it may be that the risks of harm rest in the unique interplay of drug preparation, individual user and their motivation for use.

CabbinoidsBHO is not the only potent cannabinoid product out there, however. GDS has been fascinated by synthetic cannabis and surprised at how such an ‘unpleasant’ drug has flourished. We’ve been researching them since 2010 and have found that synthetic cannabis (SCs) products are far less desirable (93 per cent prefer the real thing) and more risky than natural high potency weed, with the risk of seeking emergency medical treatment at least 30 times higher.

But this doesn’t take account of the massive profits to be made in flogging a cheap high. With emergency room presentations in some US states exceeding that of traditional drugs, and many UK prisons reporting high rates of inmate use and severe complications, it is fair to say that SCs are going to be more than a little challenge to regulators, law enforcement and health providers.

Unlike THC, SCs are full receptor agonists – meaning that there is no ceiling on how stoned you get. Manufactured with varying quality control, dosing is with varying amounts of active product being found on each gram of inert herbal material. Many SCs are much more potent (sometimes hundreds of times more) than THC, and SC products contain no counter-balance such as CBD.

The laws of common sense and basic economic theory (there are lots of natural weed supplies in the world) would suggest that the market for SC products should be dying. And yet they represent the fastest growing group of novel psychoactive drugs reported to international monitoring agencies like the EMCDDA. One reason is that when one set of synthetic cannabinoids is regulated, there’s a whole truck full waiting to be dissolved in acetone and sprayed on damiana and lettuce leaf, dried, packaged and sold for huge profits with no need for elegant hydro set-ups, electricity and water.

But why is there still demand? Why use a less desirable product when a preferable one is usually available? At least in some cases, it will be to avoid workplace drug screens. Working in a prison, I know these products have had real currency, and the same could be said for those in transport, mining and other risk-critical areas. But it’s not just avoidance of detection that can be an issue – it’s also price, potency and bang for buck, because over the last decade, high potency weed has increased in price relative to other drugs in many parts of the world. At a mean price of around €10/gram (and most people getting three to four joints out of gram), pot smoking has become an expensive habit.

For some people, using a more potent but less desirable product might just be down to economics. I bumped into a guy in a head shop in London, who was buying 3gm of cherry bomb for £25. I asked ‘wouldn’t you rather smoke some nice weed?’ ‘Yeah,’ he said, ‘I’m a weed man, but I only get three spliffs from a gram. I can get 25 spliffs out of this. I use it to sleep – saves on my use ofnice weed.’

Two minutes later in walked a mother in her mid-30s with her nine-year-old son: ‘I’ll have the usual – three blueberry bags please.’ So it is out there and people are using it. And sometimes users end up in the ER room, agitated, sweaty, paranoid and psychotic.

I also worry that, given all we know about the harms of early onset cannabis use impacting on the developing brain and increasing the risk of schizophrenia, use of SCs by young people might be a real public health issue. I have to remind them, ‘before you try and expand your brain, you have to let it grow.’

This year GDS is continuing its assessment of synthetic cannabis products. We’ll be looking at the risks of getting dependent, whether or not people get withdrawal, and whether vaporisers and potent new preparations are leading to a whole new range of health risks – or benefits.

Dr Adam Winstock is the founder of Global Drug Survey and a consultant psychiatrist, addiction medicine specialist and researcher, based in London.

To contribute experiences to GDS2015, visit https://www.globaldrugsurvey.com/GDS2015

More information at the GDS YouTube channel: http://bit.ly/1OBLjxW

DDN October 2015

October DDNIn this month’s issue of DDN…

‘Why use a less desirable product when a preferable one is usually available?’

In the October DDN, Adam Winstock explores the reasons why people are attracted to ‘risky and unpleasant’ new forms of cannabis.

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page. 

PDF Version / Virtual Magazine

DDN Help 2019

We are currently updating DDN Help and adding more resources. 

Please bear with us.

In the meantime please contact ian@cjwellings.com with any queries.

Minimum pricing ‘could breach EU law’

The Scottish Government’s plans to introduce minimum unit pricing for alcohol could potentially breach EU free trade laws, according to an initial ruling by European Court of Justice advocate general Yves Bot. While the move would not be precluded by EU legislation, it would be legal only if it could be proven that it was the most effective public health measure available, he stated. The decision has been seen as a significant setback to the government’s plans.

In the case of The Scotch Whisky Association and others versus the advocate general for Scotland, Mr Bot ruled that ‘in order to pursue the objective of combating alcohol abuse, which forms part of the objective of protecting public health, a member state can choose rules imposing a minimum retail price of alcoholic beverages – which restricts trade within the European Union and distorts competition – rather than increased taxation of those products, only on condition that it shows that the measure chosen presents additional advantages or fewer disadvantages by comparison with the alternative measure.’ Increasing taxation would be ‘capable of procuring additional advantages by contributing to the general objective of combating alcohol abuse,’ he stated.

Scottish first minister Nicola Sturgeon, however, has stressed that the legal process is still ongoing and that a final response from the European Court of Justice is needed before the case can return to the Scottish courts. ‘This initial opinion indicates that it will be for the domestic courts to take a final decision,’ she said.

‘While we must await the final outcome of this legal process, the Scottish Government remains certain that minimum unit pricing is the right measure for Scotland to reduce the harm that cheap, high-strength alcohol causes our communities,’ she continued. ‘In recent weeks statistics have shown that alcohol related deaths are rising again and that consumption may be rising again after a period of decline. We believe minimum unit pricing would save hundreds of lives in coming years and we will continue to vigorously make the case for this policy.’

Opinion of advocate general at http://curia.europa.eu